10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 28, 2024

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                    to

Commission File Number: 000-08822

CAVCO INDUSTRIES INC.

(Exact name of registrant as specified in its charter)

Delaware			56-2405642
(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification No.)
3636 North Central Ave, Ste 1200
	Phoenix	Arizona	85012
(Address of principal executive offices, including zip code)

(602) 256-6263

(Registrant's telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01	CVCO	The Nasdaq Stock Market LLC
		(Nasdaq Global Select Market)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer	☒	Accelerated Filer	☐
Non-accelerated Filer	☐	Smaller Reporting Company	☐
		Emerging Growth Company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No ☒

As of January 23, 2025, 8,013,148 shares of the registrant's Common Stock, $0.01 par value, were outstanding.

CAVCO INDUSTRIES, INC.

FORM 10-Q

December 28, 2024

TABLE OF CONTENTS

	Page
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
Consolidated Balance Sheets as of December 28, 2024 (unaudited) and March 30, 2024	1
Consolidated Statements of Comprehensive Income (unaudited) for the three and nine months ended December 28, 2024 and December 30, 2023	2
Consolidated Statements of Cash Flows (unaudited) for the nine months ended December 28, 2024 and December 30, 2023	3
Notes to Consolidated Financial Statements (unaudited)	4
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	17
Item 3. Quantitative and Qualitative Disclosures About Market Risk	24
Item 4. Controls and Procedures	25
PART II. OTHER INFORMATION
Item 1. Legal Proceedings	26
Item 1A. Risk Factors	26
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	26
Item 3. Not applicable
Item 4. Not applicable
Item 5. Other Information	26
Item 6. Exhibits	27
SIGNATURES	28

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

CAVCO INDUSTRIES, INC.

CONSOLIDATED BALANCE SHEETS

(Dollars in thousands, except per share amounts)

	December 28, 2024		March 30, 2024
ASSETS	(Unaudited)
Current assets
Cash and cash equivalents	$	362,863	$	352,687
Restricted cash, current	15,178		15,481
Accounts receivable, net	91,840		77,123
Short-term investments	16,062		18,270
Current portion of consumer loans receivable, net	33,242		20,713
Current portion of commercial loans receivable, net	34,892		40,787
Current portion of commercial loans receivable from affiliates, net	1,358		2,529
Inventories	243,299		241,339
Prepaid expenses and other current assets	79,253		82,870
Total current assets	877,987		851,799
Restricted cash	585		585
Investments	18,287		17,316
Consumer loans receivable, net	20,394		23,354
Commercial loans receivable, net	51,305		45,660
Commercial loans receivable from affiliates, net	6,798		2,065
Property, plant and equipment, net	226,126		224,199
Goodwill	121,969		121,934
Other intangibles, net	27,068		28,221
Operating lease right-of-use assets	35,248		39,027
Total assets	$	1,385,767	$	1,354,160
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable	$	26,088	$	33,531
Accrued expenses and other current liabilities	259,134		239,736
Total current liabilities	285,222		273,267
Operating lease liabilities	31,472		35,148
Other liabilities	7,206		7,759
Deferred income taxes	4,642		4,575
Stockholders' equity
Preferred stock, $0.01 par value; 1,000,000 shares authorized; No shares issued or outstanding	—		—
Common stock, $0.01 par value; 40,000,000 shares authorized; Issued 9,422,969 and 9,389,953 shares, respectively; Outstanding 8,066,549 and 8,320,718 shares, respectively	94		94
Treasury stock, at cost; 1,356,420 and 1,069,235 shares, respectively	(391,128)		(274,693)
Additional paid-in capital	286,573		281,216
Retained earnings	1,161,833		1,027,127
Accumulated other comprehensive loss	(147)		(333)
Total stockholders' equity	1,057,225		1,033,411
Total liabilities and stockholders' equity	$	1,385,767	$	1,354,160

See accompanying Notes to Consolidated Financial Statements

1

CAVCO INDUSTRIES, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Dollars in thousands, except per share amounts)

(Unaudited)

	Three Months Ended				Nine Months Ended
	December 28, 2024		December 30, 2023		December 28, 2024		December 30, 2023
Net revenue	$	522,040	$	446,769	$	1,507,100	$	1,374,674
Cost of sales	392,090		343,718		1,157,626		1,046,787
Gross profit	129,950		103,051		349,474		327,887
Selling, general and administrative expenses	65,980		63,312		197,828		186,498
Income from operations	63,970		39,739		151,646		141,389
Interest income	5,353		5,234		16,556		15,664
Interest expense	(155)		(842)		(370)		(1,365)
Other income (expense), net	168		(224)		315		557
Income before income taxes	69,336		43,907		168,147		156,245
Income tax expense	(12,874)		(7,920)		(33,441)		(32,274)
Net income	56,462		35,987		134,706		123,971
Less: net income attributable to redeemable noncontrolling interest	—		—		—		88
Net income attributable to Cavco common stockholders	$	56,462	$	35,987	$	134,706	$	123,883
Comprehensive income
Net income	$	56,462	$	35,987	$	134,706	$	123,971
Reclassification adjustment for securities sold	(97)		293		174		299
Applicable income tax benefit (expense)	20		(62)		(37)		(63)
Net change in unrealized position of investments held	8		13		62		22
Applicable income tax benefit (expense)	(2)		(3)		(13)		(5)
Comprehensive income	56,391		36,228		134,892		124,224
Less: comprehensive income attributable to redeemable noncontrolling interest	—		—		—		88
Comprehensive income attributable to Cavco common stockholders	$	56,391	$	36,228	$	134,892	$	124,136
Net income per share attributable to Cavco common stockholders
Basic	$	6.97	$	4.31	$	16.42	$	14.47
Diluted	$	6.90	$	4.27	$	16.25	$	14.34
Weighted average shares outstanding
Basic	8,096,538		8,358,389		8,203,448		8,561,209
Diluted	8,186,814		8,432,471		8,291,647		8,640,288

See accompanying Notes to Consolidated Financial Statements

2

CAVCO INDUSTRIES, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in thousands)

(Unaudited)

	Nine Months Ended
	December 28, 2024		December 30, 2023
OPERATING ACTIVITIES
Net income	$	134,706	$	123,971
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization	14,304		13,854
Provision for credit losses	(874)		(121)
Deferred income taxes	17		(1,861)
Stock-based compensation expense	6,653		4,698
Non-cash interest income, net	(787)		(1,230)
(Gain) loss on sale or retirement of property, plant and equipment, net	(19)		186
Gain on investments and sale of loans, net	(1,901)		(5,958)
Changes in operating assets and liabilities, net of acquisitions
Accounts receivable	(14,762)		18,161
Consumer loans receivable originated	(54,155)		(74,306)
Proceeds from sales of consumer loans receivable	4,408		81,752
Principal payments received on consumer loans receivable	42,618		5,480
Inventories	(1,960)		51,182
Prepaid expenses and other current assets	4,997		9,909
Commercial loans receivable originated	(87,543)		(83,509)
Principal payments received on commercial loans receivable	85,008		87,591
Accounts payable, accrued expenses and other liabilities	9,141		(23,695)
Net cash provided by operating activities	139,851		206,104
INVESTING ACTIVITIES
Purchases of property, plant and equipment	(15,288)		(13,237)
Payments for acquisitions, net	—		(19,702)
Proceeds from sale of property, plant and equipment	194		4,514
Purchases of investments	(21,588)		(7,408)
Proceeds from sale of investments	22,706		9,290
Net cash used in investing activities	(13,976)		(26,543)
FINANCING ACTIVITIES
Payments for taxes on stock option exercises and releases of equity awards	(3,425)		(1,898)
Proceeds from exercise of stock options	2,130		3,098
Payments on finance leases and other secured financings	(261)		(442)
Payments for common stock repurchases	(114,446)		(96,781)
Distributions to noncontrolling interest	—		(420)
Net cash used in financing activities	(116,002)		(96,443)
Net increase in cash, cash equivalents and restricted cash	9,873		83,118
Cash, cash equivalents and restricted cash at beginning of the fiscal year	368,753		283,490
Cash, cash equivalents and restricted cash at end of the period	$	378,626	$	366,608
Supplemental disclosures of cash flow information
Cash paid for income taxes	$	34,173	$	28,776
Cash paid for interest	$	30	$	612
Supplemental disclosures of noncash activity
Change in GNMA loans eligible for repurchase	$	730	$	(3,812)

See accompanying Notes to Consolidated Financial Statements

3

CAVCO INDUSTRIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

1. Basis of Presentation

The accompanying unaudited Consolidated Financial Statements of Cavco Industries, Inc. and its subsidiaries (collectively, "we," "us," "our," the "Company" or "Cavco") have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC") for Quarterly Reports on Form 10-Q and Article 10 of SEC Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP") have been condensed or omitted pursuant to such rules and regulations. In addition, references throughout to numbered "Notes" refer to these Notes to Consolidated Financial Statements (Unaudited), unless otherwise stated.

In the opinion of management, these financial statements include all adjustments, including normal recurring adjustments, which are necessary to fairly state the interim results for the periods presented. We have evaluated subsequent events after the balance sheet date through the date of the filing of this report with the SEC, and there were no disclosable subsequent events. These Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and the Notes to the Consolidated Financial Statements included in our 2024 Annual Report on Form 10-K for the year ended March 30, 2024, filed with the SEC ("Form 10-K").

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and accompanying Notes. Due to uncertainties, actual results could differ from the estimates and assumptions used in preparation of the Consolidated Financial Statements. The Consolidated Statements of Comprehensive Income and Consolidated Statements of Cash Flows for the interim periods are not necessarily indicative of the results or cash flows for the full year. The Company operates on a 52-53 week fiscal year ending on the Saturday nearest to March 31st of each year. Each fiscal quarter consists of 13 weeks, with an occasional fourth quarter extending to 14 weeks, if necessary, for the fiscal year to end on the Saturday nearest March 31st. The current fiscal year will end on March 29, 2025 and will include 52 weeks.

For a description of significant accounting policies used in the preparation of our Consolidated Financial Statements, please refer to Note 1 of the Notes to Consolidated Financial Statements included in the Form 10-K.

2. Recent Accounting Pronouncements

The Company considers the applicability and impact of all Accounting Standards Updates ("ASUs") issued by the Financial Accounting Standards Board ("FASB"). ASUs not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on the Company's Consolidated Financial Statements.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Taxes Disclosures, which requires greater disaggregation of income tax disclosures. The new standard requires additional information to be disclosed with respect to the income tax rate reconciliation and income taxes paid disaggregated by jurisdiction. This ASU should be applied prospectively for fiscal years beginning after December 15, 2024, with retrospective application permitted. The Company is currently evaluating the impacts of this guidance on the Company’s Consolidated Financial Statements.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires companies to enhance the disclosures about segment expenses. The new standard requires the identification and disclosure of the Company’s Chief Operating Decision Maker ("CODM"), expanded incremental line-item disclosures of significant segment expenses used by the CODM for decision-making, and the inclusion of previous annual only segment disclosure requirements on a quarterly basis. This ASU should be applied retrospectively for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impacts of this guidance on the Company’s Consolidated Financial Statements.

4

In November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses ("ASU 2024-03"), and in January 2025, the FASB issued ASU No. 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date ("ASU 2025-01"). ASU 2024-03 requires additional disclosure of the nature of expenses included in the income statement as well as disclosures about specific types of expenses included in the expense captions presented in the income statement. ASU 2024-03, as clarified by ASU 2025-01, is effective for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Both early adoption and retrospective application are permitted. The Company is currently evaluating the impact that the adoption of these standards will have on its Consolidated Financial Statements.

3. Revenue from Contracts with Customers

The following table summarizes Net revenue disaggregated by reportable segment and source (in thousands):

	Three Months Ended				Nine Months Ended
	December 28, 2024		December 30, 2023		December 28, 2024		December 30, 2023
Factory-built housing
Home sales	$	471,998	$	400,633	$	1,378,103	$	1,250,417
Delivery, setup and other revenues	28,862		26,306		67,148		67,697
	500,860		426,939		1,445,251		1,318,114
Financial services
Insurance agency commissions received from third-party insurance companies	1,246		1,229		3,920		3,145
All other sources	19,934		18,601		57,929		53,415
	21,180		19,830		61,849		56,560
	$	522,040	$	446,769	$	1,507,100	$	1,374,674

4. Investments

Investments consisted of the following (in thousands):

	December 28, 2024		March 30, 2024
Available-for-sale debt securities	$	21,783	$	18,669
Marketable equity securities	7,434		11,961
Non-marketable equity investments	5,132		4,956
	34,349		35,586
Less short-term investments	(16,062)		(18,270)
	$	18,287	$	17,316

5

The amortized cost and fair value of our investments in available-for-sale debt securities, by security type, are shown in the table below (in thousands):

	December 28, 2024				March 30, 2024
	Amortized Cost		Fair Value		Amortized Cost		Fair Value
Residential mortgage-backed securities	$	4,146	$	4,093	$	2,933	$	2,865
State and political subdivision debt securities	6,565		6,515		5,041		4,930
Corporate debt securities	11,257		11,175		11,117		10,874
	$	21,968	$	21,783	$	19,091	$	18,669

The amortized cost and fair value of our investments in available-for-sale debt securities, by contractual maturity, are shown in the table below (in thousands). Expected maturities may differ from contractual maturities as borrowers at times have the right to call or prepay obligations, with or without penalties.

	December 28, 2024
	Amortized Cost		Fair Value
Due in less than one year	$	8,402	$	8,332
Due after one year through five years	7,088		7,047
Due after five years through ten years	2,332		2,311
Mortgage-backed securities	4,146		4,093
	$	21,968	$	21,783

Net investment gains and losses on marketable equity securities were as follows (in thousands):

	Three Months Ended				Nine Months Ended
	December 28, 2024		December 30, 2023		December 28, 2024		December 30, 2023
Marketable equity securities
Net gain (loss) recognized during the period	$	(954)	$	776	$	(440)	$	1,051
Less: Net (gain) recognized on securities sold during the period	(1,649)		(235)		(1,561)		(365)
Unrealized gain (loss) recognized during the period on securities still held	$	(2,603)	$	541	$	(2,001)	$	686

5. Inventories

Inventories consisted of the following (in thousands):

	December 28, 2024		March 30, 2024
Raw materials	$	78,631	$	78,241
Work in process	30,027		27,977
Finished goods	134,641		135,121
	$	243,299	$	241,339

6

6. Consumer Loans Receivable

The following table summarizes consumer loans receivable (in thousands):

	December 28, 2024		March 30, 2024
Loans held for investment, previously securitized	$	14,476	$	16,968
Loans held for investment	11,898		12,826
Loans held for sale	23,233		15,140
Construction advances	6,042		722
	55,649		45,656
Deferred financing fees and other, net	(1,088)		(523)
Allowance for loan losses	(925)		(1,066)
	53,636		44,067
Less current portion	(33,242)		(20,713)
	$	20,394	$	23,354

The consumer loans held for investment had the following characteristics:

	December 28, 2024		March 30, 2024
Weighted average contractual interest rate	8.1	%	8.1	%
Weighted average effective interest rate	8.1	%	10.4	%
Weighted average months to maturity	210		196

The following table is a consolidated summary of the delinquency status of the outstanding principal balance of consumer loans receivable (in thousands):

	December 28, 2024		March 30, 2024
Current	$	53,709	$	43,810
31 to 60 days	996		1,063
61 to 90 days	373		131
91+ days	571		652
	$	55,649	$	45,656

7

The following table disaggregates the outstanding principal balance of consumer loans receivable by credit quality indicator and fiscal year of origination (in thousands):

	December 28, 2024
	2025		2024		2023		2022		2021		Prior		Total
Prime- FICO score 680 and greater	$	15,726	$	9,225	$	324	$	93	$	766	$	13,859	$	39,993
Near Prime- FICO score 620-679	2,426		1,325		—		—		1,033		8,874		13,658
Sub-Prime- FICO score less than 620	310		—		—		—		17		695		1,022
No FICO score	252		443		—		—		—		281		976
	$	18,714	$	10,993	$	324	$	93	$	1,816	$	23,709	$	55,649

	March 30, 2024
	2024		2023		2022		2021		2020		Prior		Total
Prime- FICO score 680 and greater	$	14,107	$	328	$	96	$	885	$	1,808	$	14,425	$	31,649
Near Prime- FICO score 620-679	1,633		—		—		1,202		942		8,684		12,461
Sub-Prime- FICO score less than 620	—		—		—		18		49		723		790
No FICO score	447		—		—		—		—		309		756
	$	16,187	$	328	$	96	$	2,105	$	2,799	$	24,141	$	45,656

As of December 28, 2024, 55% of the outstanding principal balance of the consumer loans receivable portfolio was concentrated in Texas. As of March 30, 2024, 46% of the outstanding principal balance of the consumer loans receivable portfolio was concentrated in Texas and 10% was concentrated in Florida. Other than Texas and Florida, no state had concentrations in excess of 10% of the outstanding principal balance of the consumer loans receivable as of December 28, 2024 or March 30, 2024.

7. Commercial Loans Receivable

The commercial loans receivable balance consists of direct financing arrangements for the home product needs of our independent distributors, community owners and developers.

Commercial loans receivable, net consisted of the following (in thousands):

	December 28, 2024		March 30, 2024
Loans receivable	$	94,902	$	91,938
Allowance for loan losses	(335)		(781)
Deferred financing fees, net	(214)		(116)
	94,353		91,041
Less current portion of commercial loans receivable (including from affiliates), net	(36,250)		(43,316)
	$	58,103	$	47,725

The commercial loans receivable balance had the following characteristics:

	December 28, 2024		March 30, 2024
Weighted average contractual interest rate	7.7	%	7.4	%
Weighted average months outstanding	10		12

8

Nonperforming status includes loans accounted for on a non-accrual basis and accruing loans with principal payments 90 days or more past due. As of December 28, 2024 and March 30, 2024, there were no commercial loans considered nonperforming. The following table disaggregates the outstanding principal balance of our commercial loans receivable by fiscal year of origination (in thousands):

	December 28, 2024
	2025		2024		2023		2022		2021		Total
Performing	$	54,916	$	27,832	$	8,734	$	1,466	$	1,954	$	94,902

	March 30, 2024
	2024		2023		2022		2021		2020		Total
Performing	$	57,691	$	25,066	$	4,823	$	2,144	$	2,214	$	91,938

As of December 28, 2024 and March 30, 2024, there were no commercial loans 90 days or more past due that were still accruing interest, and we were not aware of any potential problem loans that would have a material effect on the commercial loans receivable balance.

As of December 28, 2024, we had concentrations of our outstanding principal balance of the commercial loans receivable balance in New York of 18% and California of 16%. As of March 30, 2024, 18% of our outstanding principal balance of the commercial loans receivable balance was in New York. No other state had concentrations in excess of 10% of the outstanding principal balance of the commercial loans receivable as of December 28, 2024 or March 30, 2024.

As of December 28, 2024 and March 30, 2024, one independent third-party and its affiliates comprised 10% and 13%, respectively, of the net commercial loans receivable principal balance outstanding, all of which are secured.

8. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	December 28, 2024		March 30, 2024
Salaries, wages and benefits	$	44,338	$	38,125
Customer deposits	39,795		40,856
Estimated warranties	34,412		31,718
Unearned insurance premiums	33,419		33,449
Accrued volume rebates	30,481		21,167
Insurance loss reserves	12,254		10,540
Accrued insurance	12,226		14,124
Other	52,209		49,757
	$	259,134	$	239,736

9

9. Warranties

Activity in the liability for estimated warranties was as follows (in thousands):

	Three Months Ended				Nine Months Ended
	December 28, 2024		December 30, 2023		December 28, 2024		December 30, 2023
Balance at beginning of period	$	33,081	$	33,015	$	31,718	$	31,368
Charged to costs and expenses	14,322		11,341		40,403		36,956
Payments and deductions	(12,991)		(11,534)		(37,709)		(35,502)
Balance at end of period	$	34,412	$	32,822	$	34,412	$	32,822

10. Other Liabilities

The following table summarizes secured financings and other obligations (in thousands):

	December 28, 2024		March 30, 2024
Finance lease liabilities	$	6,106	$	6,166
Other secured financing	1,622		1,916
	7,728		8,082
Less current portion included in Accrued expenses and other current liabilities	(522)		(323)
	$	7,206	$	7,759

11. Debt

On November 12, 2024, the Company entered into that certain Amended and Restated Credit Agreement among the Company, Bank of America, N.A., as administrative agent, swing line lender, letter of credit issuer, and the guarantors party thereto (the "Credit Agreement"), providing for a $75 million revolving credit facility (the "Revolving Credit Facility"), including a $10 million letter of credit sub-facility. The Revolving Credit Facility matures on November 12, 2029. The Credit Agreement amends and restates the previous credit agreement between the parties entered into on November 22, 2022.

Loans under the Revolving Credit Facility will bear interest at a rate equal to (i) the Secured Overnight Financing Rate, plus a credit spread adjustment of 0.10% (as adjusted, "Term SOFR"), plus the "applicable rate" or (ii) the "base rate" (defined as the highest of (a) the Bank of America prime rate, (b) the Federal Funds rate plus 0.50%, and (c) Term SOFR plus 1.00%) plus the "applicable rate." The applicable rate will be determined in accordance with a pricing grid based on the Company's Consolidated Total Leverage Ratio (as defined in the Credit Agreement) ranging from 1.25% to 1.50% per annum for Term SOFR rate loans and from 0.25% to 0.50% per annum for base rate loans. In addition, the Company will pay a commitment fee on the unused portion of the Revolving Credit Facility of 0.20% per annum.

The Revolving Credit Facility is guaranteed, on a joint and several basis, by certain of the Company's subsidiaries. Subject to certain conditions and requirements set forth in the Credit Agreement, including the availability of additional lender commitments, the Company may request from time to time one or more term loan facilities, or increases in the aggregate commitments under the Revolving Credit Facility, in an aggregate amount not exceeding $75 million.

The Credit Agreement contains customary representations and warranties, affirmative and negative covenants (including restrictions, subject to customary exceptions, qualifications, and baskets, on the ability of the Company and its subsidiaries to incur additional indebtedness or guarantees of indebtedness, pay dividends or distributions on, redeem, repurchase, or retire capital stock, make investments, loans, advances, or acquisitions, enter into sale and leaseback transactions, engage in transactions with affiliates, create liens, transfer or sell assets, create restrictions

10

on the payment of dividends or other distributions from subsidiaries, and consolidate, merge, or transfer all or substantially all of the assets of the Company and its subsidiaries taken as a whole), and events of default (as defined in the Credit Agreement).

In addition, the Credit Agreement includes the following financial covenants (i) as of the end of any fiscal quarter, the Consolidated Total Leverage Ratio (as defined in the Credit Agreement) cannot exceed 3.25 to 1.00 and (ii) a requirement to maintain Consolidated EBITDA (as defined in the Credit Agreement) for any period of four fiscal quarters of at least $75 million.

As of December 28, 2024 and March 30, 2024, there were no borrowings outstanding under the Revolving Credit Facility or the previous credit agreement entered into on November 22, 2022 and we were in compliance with all covenants.

12. Reinsurance and Insurance Loss Reserves

Certain of Standard Casualty Company's premiums and benefits are assumed from and ceded to other insurance companies under various reinsurance agreements. We remain obligated for amounts ceded in the event that the reinsurers do not meet their obligations.

The effects of reinsurance on premiums written and earned were as follows (in thousands):

	Three Months Ended
	December 28, 2024				December 30, 2023
	Written		Earned		Written		Earned
Direct premiums	$	19,260	$	24,645	$	11,135	$	10,693
Assumed premiums—nonaffiliated	21,534		20,629		8,430		8,459
Ceded premiums—nonaffiliated	(17,387)		(17,387)		(6,406)		(6,406)
	$	23,407	$	27,887	$	13,159	$	12,746
	Nine Months Ended
	December 28, 2024				December 30, 2023
	Written		Earned		Written		Earned
Direct premiums	$	32,763	$	36,947	$	31,581	$	28,740
Assumed premiums—nonaffiliated	33,269		30,133		27,735		25,880
Ceded premiums—nonaffiliated	(25,572)		(25,572)		(18,971)		(18,971)
	$	40,460	$	41,508	$	40,345	$	35,649

11

Typical insurance policies written or assumed have a maximum coverage of $0.4 million per claim, of which we cede $0.15 million of the risk of loss per reinsurance. Therefore, our risk of loss is limited to $0.25 million per claim on typical policies, subject to the reinsurers meeting their obligations. After this limit, amounts are recoverable through reinsurance for catastrophic losses in excess of $4.0 million per occurrence, up to a maximum of $110 million in the aggregate for that occurrence.

The following details the activity in the incurred but not reported reserve for the three and nine months ended December 28, 2024 and December 30, 2023 (in thousands):

	Three Months Ended				Nine Months Ended
	December 28, 2024		December 30, 2023		December 28, 2024		December 30, 2023
Balance at beginning of period	$	14,620	$	9,154	$	10,540	$	10,939
Net incurred losses during the period	9,662		9,489		41,753		29,152
Net claim payments during the period	(12,028)		(9,189)		(40,039)		(30,637)
Balance at end of period	$	12,254	$	9,454	$	12,254	$	9,454

13. Commitments and Contingencies

Repurchase Contingencies. The maximum amount for which the Company was liable under the terms of repurchase agreements with financial institutions that provide inventory financing to independent distributors of our products approximated $122 million and $121 million at December 28, 2024 and March 30, 2024, respectively, without reduction for the estimated resale value of the homes. In the quarter ended December 28, 2024 we received one repurchase demand notice for two homes. In all cases, the estimated fair value exceeded the repurchase price so no loss reserve was deemed necessary. Our reserve for repurchase commitments, recorded in Accrued expenses and other current liabilities, was $3.2 million at December 28, 2024 and $2.9 million at March 30, 2024.

Construction-Period Mortgages. Loan contracts with off-balance sheet commitments are summarized below (in thousands):

	December 28, 2024		March 30, 2024
Construction loan contract amount	$	12,669	$	1,960
Cumulative advances	(6,042)		(722)
	$	6,627	$	1,238

Representations and Warranties of Mortgages Sold. The reserve for contingent repurchases and indemnification obligations was $0.7 million as of December 28, 2024 and $0.6 million as of March 30, 2024, included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets. There were no claim requests that resulted in the repurchase of any loans during the nine months ended December 28, 2024 or December 30, 2023.

Interest Rate Lock Commitments ("IRLCs"). As of December 28, 2024 and March 30, 2024, we had outstanding IRLCs with a notional amount of $10.1 million and $39.0 million, respectively. For the three and nine months ended December 28, 2024, we recognized insignificant non-cash losses and gains, respectively, on outstanding IRLCs. For the three and nine months ended December 30, 2023, we recognized insignificant non-cash gains and losses on outstanding IRLCs.

Forward Sales Commitments. As of December 28, 2024 and March 30, 2024, we had $15.0 million and $2.8 million in outstanding forward sales commitments for sales of mortgage backed securities and whole loan commitments (collectively, the "Commitments"), respectively. During the three and nine months ended December 28, 2024, we recognized insignificant non-cash gains. During the three and nine months ended December 30, 2023, we recognized insignificant non-cash losses.

12

Legal Matters. We are party to certain lawsuits in the ordinary course of business. Based on management's present knowledge of the facts and (in certain cases) advice of outside counsel, management does not believe that loss contingencies arising from pending matters are likely to have a material adverse effect on our consolidated financial position, liquidity or results of operations after taking into account any existing reserves, which reserves are included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets. However, future events or circumstances that may currently be unknown to management will determine whether the resolution of pending or threatened litigation or claims will ultimately have a material effect on our consolidated financial position, liquidity or results of operations in any future reporting periods.

14. Stockholders' Equity and Redeemable Noncontrolling Interest

The following tables represent changes in stockholders' equity attributable to Cavco's stockholders and redeemable noncontrolling interest during the nine months ended December 28, 2024 and December 30, 2023, respectively (dollars in thousands):

	Equity Attributable to Cavco Stockholders
				Treasury stock		Additional paid-in capital		Retained earnings		Accumulated other comprehensive (loss) income		Total
	Common Stock
	Shares	Amount
Balance, March 30, 2024	9,389,953	$	94	$	(274,693)	$	281,216	$	1,027,127	$	(333)	$	1,033,411
Net income	—	—		—		—		34,429		—		34,429
Other comprehensive income, net	—	—		—		—		—		58		58
Net issuance of common stock under stock incentive plans	11,104	—		—		(2,348)		—		—		(2,348)
Stock-based compensation	—	—		—		2,194		—		—		2,194
Common stock repurchases				(29,204)								(29,204)
Balance, June 29, 2024	9,401,057	94		(303,897)		281,062		1,061,556		(275)		1,038,540
Net income	—	—		—		—		43,815		—		43,815
Other comprehensive income, net	—	—		—		—		—		198		198
Net issuance of common stock under stock incentive plans	16,275			—		1,220		—		—		1,220
Stock-based compensation	—	—		—		2,713		—		—		2,713
Common stock repurchases	—	—		(44,509)		—		—		—		(44,509)
Balance, September 28, 2024	9,417,332	94		(348,406)		284,995		1,105,371		(77)		1,041,977
Net income	—	—		—		—		56,462		—		56,462
Other comprehensive income, net	—	—		—		—		—		(70)		(70)
Net issuance of common stock under stock incentive plans	5,637	—		—		(168)		—		—		(168)
Stock-based compensation	—	—		—		1,746		—		—		1,746
Common stock repurchases	—	—		(42,722)		—		—		—		(42,722)
Balance, December 28, 2024	9,422,969	$	94	$	(391,128)	$	286,573	$	1,161,833	$	(147)	$	1,057,225

13

	Equity Attributable to Cavco Stockholders
				Treasury stock		Additional paid-in capital		Retained earnings		Accumulated other comprehensive (loss) income		Total		Redeemable noncontrolling interest
	Common Stock
	Shares	Amount
Balance, April 1, 2023	9,337,125	$	93	$	(164,452)	$	271,950	$	869,310	$	(615)	$	976,286	$	1,219
Net income	—	—		—		—		46,357		—		46,357		54
Other comprehensive loss, net	—	—		—		—		—		(42)		(42)		—
Net issuance of common stock under stock incentive plans	10,095	—		—		(1,213)		—		—		(1,213)		—
Stock-based compensation	—	—		—		1,438		—		—		1,438		—
Distributions	—	—		—		—		—		—		—		(120)
Valuation adjustment	—	—		—		—		—		—		—		(33)
Balance, July 1, 2023	9,347,220	93		(164,452)		272,175		915,667		(657)		1,022,826		1,120
Net income	—	—		—		—		41,539		—		41,539		34
Other comprehensive income, net	—	—		—		—		—		54		54		—
Net issuance of common stock under stock incentive plans	9,201	1		—		478		—		—		479		—
Stock-based compensation	—	—		—		1,551		—		—		1,551		—
Common stock repurchases	—	—		(47,194)		—		—		—		(47,194)		—
Distributions	—	—		—		—		—		—		—		(180)
Conversion to mandatorily redeemable noncontrolling interest	—	—		—		—		—		—		—		(974)
Balance, September 30, 2023	9,356,421	94		(211,646)		274,204		957,206		(603)		1,019,255		—
Net income	—	—		—		—		35,987		—		35,987		—
Other comprehensive income, net	—	—		—		—		—		241		241		—
Net issuance of common stock under stock incentive plans	24,726	—		—		1,934		—		—		1,934		—
Stock-based compensation	—	—		—		1,709		—		—		1,709		—
Common stock repurchases	—	—		(50,426)		—		—		—		(50,426)		—
Balance, December 30, 2023	9,381,147	$	94	$	(262,072)	$	277,847	$	993,193	$	(362)	$	1,008,700	$	—

14

15. Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share (dollars in thousands, except per share amounts):

	Three Months Ended				Nine Months Ended
	December 28, 2024		December 30, 2023		December 28, 2024		December 30, 2023
Net income attributable to Cavco common stockholders	$	56,462	$	35,987	$	134,706	$	123,883
Weighted average shares outstanding
Basic	8,096,538		8,358,389		8,203,448		8,561,209
Effect of dilutive securities	90,276		74,082		88,199		79,079
Diluted	8,186,814		8,432,471		8,291,647		8,640,288
Net income per share attributable to Cavco common stockholders
Basic	$	6.97	$	4.31	$	16.42	$	14.47
Diluted	$	6.90	$	4.27	$	16.25	$	14.34
Anti-dilutive common stock equivalents excluded	—		—		169		316

16. Fair Value Measurements

The book value and estimated fair value of our financial instruments were as follows (in thousands):

	December 28, 2024				March 30, 2024
	Book Value		Estimated Fair Value		Book Value		Estimated Fair Value
Available-for-sale debt securities	$	21,783	$	21,783	$	18,669	$	18,669
Marketable equity securities	7,434		7,434		11,961		11,961
Non-marketable equity investments	5,132		5,132		4,956		4,956
Consumer loans receivable	53,636		57,114		44,067		49,105
Commercial loans receivable	94,353		79,664		91,041		80,764
Other secured financing	(1,622)		(1,536)		(1,916)		(1,841)

See Note 20, Fair Value Measurements, and the Fair Value of Financial Instruments caption in Note 1, Summary of Significant Accounting Policies, in the Form 10-K for more information on the methodologies we use in determining fair value.

Mortgage Servicing. Mortgage Servicing Rights ("MSRs") are recorded at fair value in Prepaid expenses and other current assets on the Consolidated Balance Sheets.

	December 28, 2024			March 30, 2024
Number of loans serviced with MSRs	3,693			3,842
Weighted average servicing fee (basis points)	34.80			34.79
Capitalized servicing multiple	186.29		%	188.59		%
Capitalized servicing rate (basis points)	64.83			65.61
Serviced portfolio with MSRs (in thousands)	$	458,268		$	482,898
MSRs (in thousands)	$	2,971		$	3,168

15

17. Business Segment Information

We operate principally in two segments: (1) factory-built housing, which includes wholesale and retail factory-built housing operations, and (2) financial services, which includes manufactured housing consumer finance and insurance. The following table provides selected financial data by segment (in thousands):

	Three Months Ended				Nine Months Ended
	December 28, 2024		December 30, 2023		December 28, 2024		December 30, 2023
Net revenue:
Factory-built housing	$	500,860	$	426,939	$	1,445,251	$	1,318,114
Financial services	21,180		19,830		61,849		56,560
	$	522,040	$	446,769	$	1,507,100	$	1,374,674
Income (loss) before income taxes:
Factory-built housing	$	63,150	$	42,070	$	168,155	$	154,121
Financial services	6,186		1,837		(8)		2,124
	$	69,336	$	43,907	$	168,147	$	156,245

	December 28, 2024		March 30, 2024
Total assets:
Factory-built housing	$	1,160,795	$	1,141,237
Financial services	224,972		212,923
	$	1,385,767	$	1,354,160

16

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

Statements in this Quarterly Report on Form 10-Q (the "Report") include "forward-looking statements," within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 (the "Exchange Act"), and the Private Securities Litigation Reform Act of 1995. Forward-looking statements are often characterized by the use of words such as "believes," "estimates," "expects," "projects," "may," "will," "intends," "plans," or "anticipates," or by discussions of strategy, plans or intentions. Forward-looking statements include, for example, discussions regarding the manufactured housing and site-built housing industries; discussions regarding our efforts and the efforts of other industry participants to develop the home-only loan secondary market; our financial performance and operating results; our strategy; our liquidity and financial resources; our outlook with respect to Cavco Industries, Inc. and its subsidiaries (collectively, "we," "us," "our," the "Company" or "Cavco") and the manufactured housing business in general; the expected effect of certain risks and uncertainties on our business, financial condition and results of operations; economic conditions, including concerns of a possible recession, and consumer confidence; trends in interest rates and inflation; potential acquisitions, strategic investments and other expansions; the sufficiency of our liquidity; that we may seek alternative sources of financing in the future; operational and legal risks; how we may be affected by any pandemic or outbreak; geopolitical conditions; the cost and availability of labor and raw materials; governmental regulations and legal proceedings; the availability of favorable consumer and wholesale manufactured home financing; and the ultimate outcome of our commitments and contingencies. Forward-looking statements contained in this Report speak only as of the date of this Report or, in the case of any document incorporated by reference, the date of that document. We do not intend to publicly update or revise any forward-looking statement contained in this Report or in any document incorporated herein by reference to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time, except as required by law.

Forward-looking statements involve risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements, many of which are beyond our control. To the extent that our assumptions and expectations differ from actual results, our ability to meet such forward-looking statements may be significantly hindered. Factors that could affect our results and cause them to materially differ from those contained in the forward-looking statements include, without limitation, those discussed under Risk Factors in Part I, Item 1A of our 2024 Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "Form 10-K").

Introduction

The following should be read in conjunction with the Company's unaudited Consolidated Financial Statements and the related Notes that appear in Part I, Item 1 of this Report. References to "Note" or "Notes" pertain to the Notes to our unaudited Consolidated Financial Statements.

Company Overview

Headquartered in Phoenix, Arizona, we design and produce factory-built homes primarily distributed through a network of independent and Company-owned retailers, planned community operators and residential developers. We are one of the largest producers of manufactured homes in the United States, based on reported wholesale shipments. Our products are marketed under a variety of brand names including Cavco, Fleetwood, Palm Harbor, Nationwide, Fairmont, Friendship, Chariot Eagle, Destiny, Commodore, Colony, Pennwest, R-Anell, Manorwood, MidCountry and Solitaire. We are also a leading producer of park model RVs, vacation cabins and factory-built commercial structures. Our finance subsidiary, CountryPlace Acceptance Corp. ("CountryPlace"), is an approved Federal National Mortgage Association and Federal Home Loan Mortgage Corporation seller/servicer, and a Government National Mortgage Association ("GNMA") mortgage-backed securities issuer that offers conforming mortgages, non-conforming mortgages and home-only loans to purchasers of factory-built homes. Our insurance subsidiary, Standard Casualty Company, provides property and casualty insurance primarily to owners of manufactured homes.

17

We operate a total of 31 homebuilding production lines with domestic locations in Millersburg and Woodburn, Oregon; Riverside, California; Nampa, Idaho; Phoenix, Glendale and Goodyear, Arizona; Deming, New Mexico; Duncan, Oklahoma; Austin, Fort Worth, Seguin and Waco, Texas; Montevideo, Minnesota; Dorchester, Wisconsin; Nappanee and Goshen, Indiana; Lafayette, Tennessee; Douglas and Moultrie, Georgia; Shippenville (two lines) and Emlenton, Pennsylvania; Martinsville and Rocky Mount, Virginia; Crouse and Hamlet, North Carolina; Ocala and Plant City, Florida; and two international lines in Ojinaga, Mexico. We distribute our homes through a large network of independent distribution points and 79 Company-owned U.S. retail stores, of which 47 are located in Texas.

Company and Industry Outlook

According to data reported by the Manufactured Housing Institute, industry home shipments for the calendar year through November 2024 were 96,240, an increase of 16.3% compared to 82,784 shipments in the same calendar period last year. The manufactured housing industry offers solutions to the housing crisis with lower average price per square foot than a site-built home and the comparatively lower cost associated with manufactured home ownership, which remains competitive with rental housing.

The two largest manufactured housing consumer demographics, young adults and those who are age 55 and older, are both growing. "First-time" and "move-up" buyers of affordable homes are historically among the largest segments of new manufactured home purchasers. Included in this group are lower-income households that are particularly affected by periods of low employment rates and underemployment. Consumer confidence is especially important among manufactured home buyers interested in our products for seasonal or retirement living.

We employ a concerted effort to identify niche market opportunities where our diverse product lines and custom building capabilities provide us with a competitive advantage. We are focused on building quality, energy efficient homes for the modern home buyer. Our green building initiatives involve the creation of an energy efficient envelope, including higher utilization of renewable materials and provide lower utility costs. We also build homes designed to use alternative energy sources, such as solar.

We maintain a conservative cost structure in an effort to build added value into our homes and we work diligently to maintain a solid financial position. Our balance sheet strength, including the position in cash and cash equivalents, helps avoid liquidity problems and enables us to act effectively as market opportunities or challenges present themselves.

We continue to make certain commercial loan programs available to members of our wholesale distribution chain. Under direct commercial loan arrangements, we provide funds for financed home purchases by distributors, community operators and residential developers (see Note 7, Commercial Loans Receivable, to the unaudited Consolidated Financial Statements). Our involvement in commercial lending helps to increase the availability of manufactured home financing to distributors, community operators and residential developers and provides additional opportunities for product exposure to potential home buyers. While these initiatives support our ongoing efforts to expand product distribution, they also expose us to risks associated with the creditworthiness of this customer base and our inventory financing partners.

The lack of an efficient secondary market for manufactured home-only loans and the limited number of institutions providing such loans results in higher borrowing costs for home-only loans and continues to constrain industry growth. We work independently and with other industry participants to develop secondary market opportunities for manufactured home-only loan and non-conforming mortgage portfolios and expand lending availability in the industry. We also develop and invest in home-only lending programs to grow sales of homes through traditional distribution points. We believe that growing our investment and participation in home-only lending may provide additional sales growth opportunities for our factory-built housing operations and reduce our customers' dependence on independent lenders for this source of financing.

18

Key housing building materials include wood, wood products, steel, gypsum wallboard, windows, doors fiberglass insulation, carpet, vinyl, fasteners, plumbing materials, aluminum, appliances and electrical items. Fluctuations in the cost of materials and labor may affect gross margins from home sales to the extent that an increase in costs cannot be efficiently matched to the home sales price. Pricing and availability of certain raw materials have been volatile due to a number of factors in the current environment. We continue to monitor and react to inflation in the cost of these materials by maintaining a focus on our product pricing in response to higher materials costs, but such product pricing increases may lag behind the escalation of such costs. From time to time and to varying degrees, we may experience shortages in the availability of materials and/or labor in the markets served. Availability of these inputs has not caused significant production halts in the current period, but we have experienced periodic shutdowns in other periods and shortages of primary building materials have caused production inefficiencies as we have needed to change processes in response to the delay in materials. These shortages may also result in extended order backlogs, delays in the delivery of homes and reduced gross margins from home sales.

Our backlog at December 28, 2024 was $224 million compared to $276 million at September 28, 2024, a decrease of $52 million, and up $64 million compared to $160 million at December 30, 2023.

While it is difficult to predict the future of housing demand, employee availability, supply chain and Company performance and operations, maintaining an appropriately sized and well-trained workforce is key to meeting demand. We continually review the wage rates of our production employees and have established other monetary incentive and benefit programs, with a goal of providing competitive compensation. We are also working to more extensively use web-based recruiting tools, update our recruitment brochures and improve the appearance and appeal of our manufacturing facilities to improve the recruitment and retention of qualified production employees and reduce annualized turnover rates.

19

Results of Operations

Net Revenue

	Three Months Ended
($ in thousands, except revenue per home sold)	December 28, 2024		December 30, 2023		Change
Factory-built housing	$	500,860	$	426,939	$	73,921	17.3	%
Financial services	21,180		19,830		1,350		6.8	%
	$	522,040	$	446,769	$	75,271	16.8	%
Factory-built homes sold
by Company-owned retail sales centers	1,075		1,026		49		4.8	%
to independent retailers, builders, communities and developers	3,984		3,134		850		27.1	%
	5,059		4,160		899		21.6	%
Net factory-built housing revenue per home sold	$	99,004	$	102,630	$	(3,626)	(3.5)	%
	Nine Months Ended
($ in thousands, except revenue per home sold)	December 28, 2024		December 30, 2023		Change
Factory-built housing	$	1,445,251	$	1,318,114	$	127,137	9.6	%
Financial services	61,849		56,560		5,289		9.4	%
	$	1,507,100	$	1,374,674	$	132,426	9.6	%
Factory-built homes sold
by Company-owned retail sales centers	3,120		2,999		121		4.0	%
to independent retailers, builders, communities and developers	11,573		9,991		1,582		15.8	%
	14,693		12,990		1,703		13.1	%
Net factory-built housing revenue per home sold	$	98,363	$	101,471	$	(3,108)	(3.1)	%

Factory-built housing Net revenue increased for the three and nine months ended December 28, 2024 due to higher home sales volume, partially offset by a decrease in Net revenue per home sold primarily caused by a lower proportion of homes sold through our Company-owned stores.

Net factory-built housing revenue per home sold is a volatile metric dependent upon several factors. A primary factor is the price disparity between sales of homes to independent distributors, builders, communities and developers and sales of homes to consumers by Company-owned retail stores. Wholesale sales prices are primarily comprised of the home and the cost to ship the home from a homebuilding facility to the home-site. Retail home prices include these items and retail markup, as well as items that are largely subject to home buyer discretion, including, but not limited to, installation, utility connections, site improvements, landscaping and additional services. Our homes are constructed in one or more floor sections ("modules") which are then installed on the customer's site. Changes in the number of modules per home, the selection of different home types/models and optional home upgrades create changes in product mix, also causing fluctuations in this metric.

For the three and nine months ended December 28, 2024, Financial services Net revenue increased primarily due to higher insurance premiums.

20

Gross Profit

	Three Months Ended
($ in thousands)	December 28, 2024			December 30, 2023			Change
Factory-built housing	$	118,193		$	95,756		$	22,437	23.4	%
Financial services	11,757			7,295			4,462		61.2	%
	$	129,950		$	103,051		$	26,899	26.1	%
Gross profit as % of Net revenue
Consolidated	24.9		%	23.1		%	N/A		1.8	%
Factory-built housing	23.6		%	22.4		%	N/A		1.2	%
Financial services	55.5		%	36.8		%	N/A		18.7	%
	Nine Months Ended
($ in thousands)	December 28, 2024			December 30, 2023			Change
Factory-built housing	$	333,223		$	309,631		$	23,592	7.6	%
Financial services	16,251			18,256			(2,005)		(11.0)	%
	$	349,474		$	327,887		$	21,587	6.6	%
Gross profit as % of Net revenue
Consolidated	23.2		%	23.9		%	N/A		(0.7)	%
Factory-built housing	23.1		%	23.5		%	N/A		(0.4)	%
Financial services	26.3		%	32.3		%	N/A		(6.0)	%

Factory-built housing Gross profit as a percentage of Net revenue for the three months increased due to lower input costs per unit and efficiencies gained on increased production, partially offset by lower average selling price. Gross profit housing in dollars for the nine months decreased due to lower average selling price, partially offset by lower input costs per unit.

Financial services Gross profit in dollars and as a percentage of Financial services Net revenue for the three months increased due to higher insurance premiums and lower claim losses. For the nine months, Gross profit in dollars and as a percentage of Net revenue decreased due to higher expenses from higher storm and fire activity, partially offset by higher insurance premiums.

21

Selling, General and Administrative Expenses

	Three Months Ended
($ in thousands)	December 28, 2024			December 30, 2023			Change
Factory-built housing	$	60,409		$	57,854		$	2,555	4.4	%
Financial services	5,571			5,458			113		2.1	%
	$	65,980		$	63,312		$	2,668	4.2	%
Selling, general and administrative expenses as % of Net revenue	12.6		%	14.2		%	N/A		(1.6)	%
	Nine Months Ended
($ in thousands)	December 28, 2024			December 30, 2023			Change
Factory-built housing	$	181,569		$	170,330		$	11,239	6.6	%
Financial services	16,259			16,168			91		0.6	%
	$	197,828		$	186,498		$	11,330	6.1	%
Selling, general and administrative expenses as % of Net revenue	13.1		%	13.6		%	N/A		(0.5)	%

Factory-built housing Selling, general and administrative expenses increased for the three and nine months ended December 28, 2024 as a result of increases in variable compensation driven by higher incentive compensation in the third quarter and as a result of increases in compensation related to acquired retail locations for both periods.

Financial services Selling, general and administrative expenses for the three months increased primarily due to increases in compensation year over year. For the nine months ended it was essentially flat.

22

Other Components of Net Income

	Three Months Ended
($ in thousands)	December 28, 2024			December 30, 2023			Change
Interest income	$	5,353		$	5,234		$	119	2.3	%
Interest expense	(155)			(842)			(687)		(81.6)	%
Other income (expense), net	168			(224)			392		175.0	%
Income tax expense	(12,874)			(7,920)			4,954		62.6	%
Effective tax rate	18.6		%	18.0		%	N/A		0.6	%
	Nine Months Ended
($ in thousands)	December 28, 2024			December 30, 2023			Change
Interest income	$	16,556		$	15,664		$	892	5.7	%
Interest expense	(370)			(1,365)			(995)		(72.9)	%
Other income, net	315			557			(242)		43.4	%
Income tax expense	(33,441)			(32,274)			1,167		3.6	%
Effective tax rate	19.9		%	20.7		%	N/A		(0.8)	%

Interest income consists primarily of interest earned on cash balances held in money market accounts, and interest earned on commercial floorplan lending. Interest expense consists primarily of interest related to finance leases.

Other income (expense), net primarily consists of realized and unrealized gains and losses on corporate investments and gains and losses from the sale of property, plant and equipment.

Income tax expense increased for both periods ended compared to the prior year periods primarily due to higher profit before income taxes.

Liquidity and Capital Resources

We believe that cash and cash equivalents at December 28, 2024, together with cash flow from operations, will be sufficient to fund our operations, cover our obligations and provide for growth for the next 12 months and into the foreseeable future. We maintain cash in U.S. Treasury and other money market funds, some of which is in excess of federally insured limits, but we have not experienced any losses with regards to such excesses. We expect to continue to evaluate potential acquisitions of, or strategic investments in, businesses that are complementary to the Company, as well as other expansion opportunities. Such transactions may require the use of cash and have other impacts on our liquidity and capital resources. We believe we have sufficient liquid resources including our $75 million Revolving Credit Facility, which may be increased from time to time through additional term facilities up to an aggregate amount of $75 million, and no amounts are outstanding. Depending on our operating results and strategic opportunities, we may choose to seek additional or alternative sources of financing in the future. There can be no assurance that such financing would be available on satisfactory terms, if at all. If this financing were not available, it could be necessary for us to reevaluate our long-term operating plans to make more efficient use of our existing capital resources at such time. The exact nature of any changes to our plans that would be considered depends on various factors, such as conditions in the factory-built housing industry and general economic conditions outside of our control.

State insurance regulations restrict the amount of dividends that can be paid to stockholders of insurance companies. As a result, the assets owned by our insurance subsidiary are generally not available to satisfy the claims of Cavco or its other subsidiaries. We believe that stockholders' equity at the insurance subsidiary remains sufficient and do not believe that the ability to pay ordinary dividends to Cavco at anticipated levels will be restricted per state regulations.

23

The following is a summary of the Company's cash flows for the nine months ended December 28, 2024 and December 30, 2023, respectively:

	Nine Months Ended
(in thousands)	December 28, 2024		December 30, 2023		$ Change
Cash, cash equivalents and restricted cash at beginning of the fiscal year	$	368,753	$	283,490	$	85,263
Net cash provided by operating activities	139,851		206,104		(66,253)
Net cash used in investing activities	(13,976)		(26,543)		12,567
Net cash used in financing activities	(116,002)		(96,443)		(19,559)
Cash, cash equivalents and restricted cash at end of the period	$	378,626	$	366,608	$	12,018

Net cash provided by operating activities decreased primarily from increases in working capital, primarily from increases in Inventory and Accounts receivable. This was partially offset by higher Net income and changes in Accounts payable, accrued expenses due primarily to increased customer deposits and volume rebates due to customers.

Consumer loan originations decreased $20.1 million to $54.2 million for the nine months ended December 28, 2024 from $74.3 million for the nine months ended December 30, 2023, and proceeds from sales of consumer loans decreased $77.3 million to $4.4 million for the nine months ended December 28, 2024 from $81.8 million for the nine months ended December 30, 2023.

Commercial loan originations increased $4.0 million to $87.5 million for the nine months ended December 28, 2024 from $83.5 million for the nine months ended December 30, 2023. Proceeds from the collection on commercial loans provided $85.0 million this year, compared to $87.6 million in the prior year, a net decrease of $2.6 million.

The change in Net cash used in investing activities is primarily due to the prior year period including payments for acquisitions that did not repeat in the current year.

The change in Net cash used in financing activities was primarily due to the repurchase of more shares of common stock and at a higher average daily stock price.

Obligations and Commitments. There were no material changes to the obligations and commitments as set forth in the Form 10-K.

Critical Accounting Estimates

There have been no significant changes to our critical accounting estimates during the nine months ended December 28, 2024, as compared to those disclosed in Part II, Item 7 of the Form 10-K, under the heading "Critical Accounting Estimates," which provides a discussion of the critical accounting estimates that management believes are critical to the Company's operating results or may affect significant judgments and estimates used in the preparation of the Company's Consolidated Financial Statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes from the quantitative and qualitative disclosures about market risk previously disclosed in the Form 10-K.

24

Item 4. Controls and Procedures

(a) Disclosure Controls and Procedures

The Company carried out an evaluation, under the supervision and with the participation of the Company's management, including its President and Chief Executive Officer and its Chief Financial Officer, of the effectiveness of its disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)). Based upon that evaluation, the Company's President and Chief Executive Officer and its Chief Financial Officer concluded that, as of December 28, 2024, its disclosure controls and procedures were effective.

(b) Changes in Internal Control Over Financial Reporting

There has been no change in the Company's internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the fiscal quarter ended December 28, 2024 that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

25

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

See the information under the "Legal Matters" caption in Note 13, Commitments and Contingencies to the unaudited Consolidated Financial Statements, which is incorporated herein by reference.

Item 1A. Risk Factors

In addition to the other information set forth in this Report, you should carefully consider the factors discussed in Part I, Item 1A, Risk Factors, in the Form 10-K, which could materially affect our business, financial condition or future results. The risks described in this Report and in the Form 10-K are not the only risks facing the Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or future results.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

The following table sets forth repurchases of our common stock during the third quarter of fiscal year 2025:

Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs (in thousands)
September 29, 2024 to       October 2, 2024	72,529	$	424.63	72,529	$	22,554
October 3, 2024 to       November 30, 2024	10,080	456.36		10,080	117,954
December 1, 2024 to       December 28, 2024	15,475	449.62		15,475	110,997
	98,084			98,084

The payment of dividends to Company stockholders is subject to the discretion of the Board of Directors, and various factors may prevent us from paying dividends. Such factors include Company cash requirements, covenants of our credit agreement and liquidity or other requirements of state, corporate and other laws.

Item 5. Other Information

Rule 10b5-1 Trading Plans

On December 10, 2024, Julia Sze, a director, terminated her previously adopted plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1(c). This plan was entered into on August 9, 2024, was set to end on December 10, 2024, and provided for the sale of 250 shares of our Common Stock.

On December 4, 2024, David Greenblatt, a director, adopted a programmed plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1(c) (the "Greenblatt 10b5-1 Plan"). This plan provides for a first possible trade date of March 5, 2025, and terminates automatically on April 15, 2025, if not before. The aggregate number of shares to potentially be sold pursuant to the Greenblatt 10b5-1 Plan is up to 4,000 shares of Common Stock.

On December 5, 2024, Seth Schuknecht, Executive Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary also adopted a programmed plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1(c) (the "Schuknecht 10b5-1 Plan"). This plan provides for a first possible trade date of

26

March 6, 2025, and terminates automatically on October 31, 2025, if not before. The aggregate number of shares to potentially be sold pursuant to the Schuknecht 10b5-1 Plan is up to 167 shares of Common Stock.

During the three months ended December 28, 2024, no director or officer of the Company, other than Ms. Sze, Mr. Greenblatt, and Mr. Schuknecht, adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408 of Regulation S-K.

Item 6. Exhibits

Exhibit No.		Exhibit
31.1	(1)	Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 - Rule 13a-14(a)/15d-14(a)
31.2	(1)	Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 - Rule 13a-14(a)/15d-14(a)
32	(2)	Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. 1350, Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS		Inline XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

(1) Filed herewith.

(2) Furnished herewith.

All other items required under Part II are omitted because they are not applicable.

27

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Cavco Industries, Inc.
Registrant
Signature	Title	Date
/s/ William C. Boor	Director, President and Chief Executive Officer	January 31, 2025
William C. Boor	(Principal Executive Officer)
/s/ Allison K. Aden	Executive Vice President, Chief Financial Officer and Treasurer	January 31, 2025
Allison K. Aden	(Principal Financial Officer)

28

EX-31.1

Exhibit 31.1

Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, William C. Boor, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Cavco Industries, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated:	January 31, 2025
By:	/s/ William C. Boor
	William C. Boor
	President and Chief Executive Officer (Principal Executive Officer)

EX-31.2

Exhibit 31.2

Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Allison K. Aden, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Cavco Industries, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated:	January 31, 2025
By:	/s/ Allison K. Aden
	Allison K. Aden
	Executive Vice President, Chief Financial Officer & Treasurer (Principal Financial Officer)

EX-32

Exhibit 32

Certification Pursuant to 18 U.S.C. 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Cavco Industries, Inc. (the "Registrant") on Form 10-Q for the period ending December 28, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), we, William C. Boor, President and Chief Executive Officer, and Allison K. Aden, Executive Vice President, Chief Financial Officer & Treasurer, of the Registrant, each certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

January 31, 2025

/s/ William C. Boor

William C. Boor

President and Chief Executive Officer
(Principal Executive Officer)

/s/ Allison K. Aden

Allison K. Aden

Executive Vice President, Chief Financial Officer & Treasurer
(Principal Financial Officer)

XML

Cover Page - shares	9 Months Ended
	Dec. 28, 2024	Jan. 23, 2025
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 28, 2024
Document Transition Report	false
Entity File Number	000-08822
Entity Registrant Name	CAVCO INDUSTRIES INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	56-2405642
Entity Address, Address Line One	3636 North Central Ave, Ste 1200
Entity Address, City or Town	Phoenix
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85012
City Area Code	602
Local Phone Number	256-6263
Title of 12(b) Security	Common Stock, par value $0.01
Trading Symbol	CVCO
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		8,013,148
Entity Central Index Key	0000278166
Document Fiscal Year Focus	2025
Amendment Flag	false
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--03-29

XML

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 28, 2024	Mar. 30, 2024
Current assets
Cash and cash equivalents	$ 362,863	$ 352,687
Restricted cash, current	15,178	15,481
Accounts receivable, net	91,840	77,123
Short-term investments	16,062	18,270
Inventories	243,299	241,339
Prepaid expenses and other current assets	79,253	82,870
Total current assets	877,987	851,799
Restricted cash	585	585
Investments	18,287	17,316
Property, plant and equipment, net	226,126	224,199
Goodwill	121,969	121,934
Other intangibles, net	27,068	28,221
Operating lease right-of-use assets	35,248	39,027
Total assets	1,385,767	1,354,160
Current liabilities
Accounts payable	26,088	33,531
Accrued expenses and other current liabilities	259,134	239,736
Total current liabilities	285,222	273,267
Operating lease liabilities	31,472	35,148
Other liabilities	7,206	7,759
Deferred income taxes	4,642	4,575
Stockholders' equity
Preferred stock, $0.01 par value; 1,000,000 shares authorized; No shares issued or outstanding	0	0
Common stock, $0.01 par value; 40,000,000 shares authorized; Issued 9,422,969 and 9,389,953 shares, respectively; Outstanding 8,066,549 and 8,320,718 shares, respectively	94	94
Treasury stock, at cost; 1,356,420 and 1,069,235 shares, respectively	(391,128)	(274,693)
Additional paid-in capital	286,573	281,216
Retained earnings	1,161,833	1,027,127
Accumulated other comprehensive loss	(147)	(333)
Total stockholders' equity	1,057,225	1,033,411
Total liabilities and stockholders' equity	1,385,767	1,354,160
Consumer Loans Receivable
Current assets
Current portion of loans receivable, net	33,242	20,713
Loans receivable, net	20,394	23,354
Commercial Loans Receivable
Current assets
Current portion of loans receivable, net	36,250	43,316
Loans receivable, net	58,103	47,725
Commercial Loans Receivable | Nonrelated Party
Current assets
Current portion of loans receivable, net	34,892	40,787
Loans receivable, net	51,305	45,660
Commercial Loans Receivable | Related Party
Current assets
Current portion of loans receivable, net	1,358	2,529
Loans receivable, net	$ 6,798	$ 2,065

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Income Statement [Abstract]
Net revenue	$ 522,040	$ 446,769	$ 1,507,100	$ 1,374,674
Cost of sales	392,090	343,718	1,157,626	1,046,787
Gross profit	129,950	103,051	349,474	327,887
Selling, general and administrative expenses	65,980	63,312	197,828	186,498
Income from operations	63,970	39,739	151,646	141,389
Interest income	5,353	5,234	16,556	15,664
Interest expense	(155)	(842)	(370)	(1,365)
Other income (expense), net	168	(224)	315	557
Income before income taxes	69,336	43,907	168,147	156,245
Income tax expense	(12,874)	(7,920)	(33,441)	(32,274)
Net income	56,462	35,987	134,706	123,971
Less: net income attributable to redeemable noncontrolling interest	0	0	0	88
Net income attributable to Cavco common stockholders	56,462	35,987	134,706	123,883
Comprehensive income
Net income	56,462	35,987	134,706	123,971
Reclassification adjustment for securities sold	(97)	293	174	299
Applicable income tax benefit (expense)	20	(62)	(37)	(63)
Net change in unrealized position of investments held	8	13	62	22
Applicable income tax benefit (expense)	(2)	(3)	(13)	(5)
Comprehensive income	56,391	36,228	134,892	124,224
Less: comprehensive income attributable to redeemable noncontrolling interest	0	0	0	88
Comprehensive income attributable to Cavco common stockholders	$ 56,391	$ 36,228	$ 134,892	$ 124,136
Net income per share attributable to Cavco common stockholders
Basic (in usd per share)	$ 6.97	$ 4.31	$ 16.42	$ 14.47
Diluted (in usd per share)	$ 6.90	$ 4.27	$ 16.25	$ 14.34
Weighted average shares outstanding
Basic (in shares)	8,096,538	8,358,389	8,203,448	8,561,209
Diluted (in shares)	8,186,814	8,432,471	8,291,647	8,640,288

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023
OPERATING ACTIVITIES
Net income	$ 134,706	$ 123,971
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization	14,304	13,854
Provision for credit losses	(874)	(121)
Deferred income taxes	17	(1,861)
Stock-based compensation expense	6,653	4,698
Non-cash interest income, net	(787)	(1,230)
(Gain) loss on sale or retirement of property, plant and equipment, net	(19)	186
Gain on investments and sale of loans, net	(1,901)	(5,958)
Changes in operating assets and liabilities, net of acquisitions
Accounts receivable	(14,762)	18,161
Proceeds from sales of consumer loans receivable	4,408	81,752
Inventories	(1,960)	51,182
Prepaid expenses and other current assets	4,997	9,909
Accounts payable, accrued expenses and other liabilities	9,141	(23,695)
Net cash provided by operating activities	139,851	206,104
INVESTING ACTIVITIES
Purchases of property, plant and equipment	(15,288)	(13,237)
Payments for acquisitions, net	0	(19,702)
Proceeds from sale of property, plant and equipment	194	4,514
Purchases of investments	(21,588)	(7,408)
Proceeds from sale of investments	22,706	9,290
Net cash used in investing activities	(13,976)	(26,543)
FINANCING ACTIVITIES
Payments for taxes on stock option exercises and releases of equity awards	(3,425)	(1,898)
Proceeds from exercise of stock options	2,130	3,098
Payments on finance leases and other secured financings	(261)	(442)
Payments for common stock repurchases	(114,446)	(96,781)
Distributions to noncontrolling interest	0	(420)
Net cash used in financing activities	(116,002)	(96,443)
Net increase in cash, cash equivalents and restricted cash	9,873	83,118
Cash, cash equivalents and restricted cash at beginning of the fiscal year	368,753	283,490
Cash, cash equivalents and restricted cash at end of the period	378,626	366,608
Supplemental disclosures of cash flow information
Cash paid for income taxes	34,173	28,776
Cash paid for interest	30	612
Supplemental disclosures of noncash activity
Change in GNMA loans eligible for repurchase	730	(3,812)
Consumer Loans Receivable
Changes in operating assets and liabilities, net of acquisitions
Loans receivable originated	(54,155)	(74,306)
Principal payments received on loans receivable	42,618	5,480
Commercial Loans Receivable
Changes in operating assets and liabilities, net of acquisitions
Loans receivable originated	(87,543)	(83,509)
Principal payments received on loans receivable	$ 85,008	$ 87,591

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 28, 2024	Mar. 30, 2024
Statement of Financial Position [Abstract]
Preferred stock, par value (in usd per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in usd per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	40,000,000	40,000,000
Common stock, shares issued (in shares)	9,422,969	9,389,953
Common stock, shares outstanding (in shares)	8,066,549	8,320,718
Treasury stock, common shares (in shares)	1,356,420	1,069,235

XML

Basis of Presentation

9 Months Ended

Dec. 28, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying unaudited Consolidated Financial Statements of Cavco Industries, Inc. and its subsidiaries (collectively, "we," "us," "our," the "Company" or "Cavco") have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC") for Quarterly Reports on Form 10-Q and Article 10 of SEC Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP") have been condensed or omitted pursuant to such rules and regulations. In addition, references throughout to numbered "Notes" refer to these Notes to Consolidated Financial Statements (Unaudited), unless otherwise stated.

In the opinion of management, these financial statements include all adjustments, including normal recurring adjustments, which are necessary to fairly state the interim results for the periods presented. We have evaluated subsequent events after the balance sheet date through the date of the filing of this report with the SEC, and there were no disclosable subsequent events. These Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and the Notes to the Consolidated Financial Statements included in our 2024 Annual Report on Form 10-K for the year ended March 30, 2024, filed with the SEC ("Form 10-K").

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and accompanying Notes. Due to uncertainties, actual results could differ from the estimates and assumptions used in preparation of the Consolidated Financial Statements. The Consolidated Statements of Comprehensive Income and Consolidated Statements of Cash Flows for the interim periods are not necessarily indicative of the results or cash flows for the full year. The Company operates on a 52-53 week fiscal year ending on the Saturday nearest to March 31st of each year. Each fiscal quarter consists of 13 weeks, with an occasional fourth quarter extending to 14 weeks, if necessary, for the fiscal year to end on the Saturday nearest March 31st. The current fiscal year will end on March 29, 2025 and will include 52 weeks.

For a description of significant accounting policies used in the preparation of our Consolidated Financial Statements, please refer to Note 1 of the Notes to Consolidated Financial Statements included in the Form 10-K.

XML

Recent Accounting Pronouncements

9 Months Ended

Dec. 28, 2024

Accounting Policies [Abstract]

Recent Accounting Pronouncements

Recent Accounting Pronouncements

The Company considers the applicability and impact of all Accounting Standards Updates ("ASUs") issued by the Financial Accounting Standards Board ("FASB"). ASUs not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on the Company's Consolidated Financial Statements.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Taxes Disclosures, which requires greater disaggregation of income tax disclosures. The new standard requires additional information to be disclosed with respect to the income tax rate reconciliation and income taxes paid disaggregated by jurisdiction. This ASU should be applied prospectively for fiscal years beginning after December 15, 2024, with retrospective application permitted. The Company is currently evaluating the impacts of this guidance on the Company’s Consolidated Financial Statements.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires companies to enhance the disclosures about segment expenses. The new standard requires the identification and disclosure of the Company’s Chief Operating Decision Maker ("CODM"), expanded incremental line-item disclosures of significant segment expenses used by the CODM for decision-making, and the inclusion of previous annual only segment disclosure requirements on a quarterly basis. This ASU should be applied retrospectively for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impacts of this guidance on the Company’s Consolidated Financial Statements.

In November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses ("ASU 2024-03"), and in January 2025, the FASB issued ASU No. 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date ("ASU 2025-01"). ASU 2024-03 requires additional disclosure of the nature of expenses included in the income statement as well as disclosures about specific types of expenses included in the expense captions presented in the income statement. ASU 2024-03, as clarified by ASU 2025-01, is effective for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Both early adoption and retrospective application are permitted. The Company is currently evaluating the impact that the adoption of these standards will have on its Consolidated Financial Statements.

XML

Revenue from Contracts with Customers

9 Months Ended

Dec. 28, 2024

Revenue from Contract with Customer [Abstract]

Revenue from Contracts with Customers

Revenue from Contracts with Customers

The following table summarizes Net revenue disaggregated by reportable segment and source (in thousands):

	Three Months Ended				Nine Months Ended
	December 28, 2024		December 30, 2023		December 28, 2024		December 30, 2023
Factory-built housing
Home sales	$	471,998	$	400,633	$	1,378,103	$	1,250,417
Delivery, setup and other revenues	28,862		26,306		67,148		67,697
	500,860		426,939		1,445,251		1,318,114
Financial services
Insurance agency commissions received from third-party insurance companies	1,246		1,229		3,920		3,145
All other sources	19,934		18,601		57,929		53,415
	21,180		19,830		61,849		56,560
	$	522,040	$	446,769	$	1,507,100	$	1,374,674

XML

Investments

9 Months Ended

Dec. 28, 2024

Investments, Debt and Equity Securities [Abstract]

Investments

Investments

Investments consisted of the following (in thousands):

	December 28, 2024		March 30, 2024
Available-for-sale debt securities	$	21,783	$	18,669
Marketable equity securities	7,434		11,961
Non-marketable equity investments	5,132		4,956
	34,349		35,586
Less short-term investments	(16,062)		(18,270)
	$	18,287	$	17,316

The amortized cost and fair value of our investments in available-for-sale debt securities, by security type, are shown in the table below (in thousands):

	December 28, 2024				March 30, 2024
	Amortized Cost		Fair Value		Amortized Cost		Fair Value
Residential mortgage-backed securities	$	4,146	$	4,093	$	2,933	$	2,865
State and political subdivision debt securities	6,565		6,515		5,041		4,930
Corporate debt securities	11,257		11,175		11,117		10,874
	$	21,968	$	21,783	$	19,091	$	18,669

The amortized cost and fair value of our investments in available-for-sale debt securities, by contractual maturity, are shown in the table below (in thousands). Expected maturities may differ from contractual maturities as borrowers at times have the right to call or prepay obligations, with or without penalties.

	December 28, 2024
	Amortized Cost		Fair Value
Due in less than one year	$	8,402	$	8,332
Due after one year through five years	7,088		7,047
Due after five years through ten years	2,332		2,311
Mortgage-backed securities	4,146		4,093
	$	21,968	$	21,783

Net investment gains and losses on marketable equity securities were as follows (in thousands):

	Three Months Ended				Nine Months Ended
	December 28, 2024		December 30, 2023		December 28, 2024		December 30, 2023
Marketable equity securities
Net gain (loss) recognized during the period	$	(954)	$	776	$	(440)	$	1,051
Less: Net (gain) recognized on securities sold during the period	(1,649)		(235)		(1,561)		(365)
Unrealized gain (loss) recognized during the period on securities still held	$	(2,603)	$	541	$	(2,001)	$	686

XML

Inventories

9 Months Ended

Dec. 28, 2024

Inventory Disclosure [Abstract]

Inventories

Inventories

Inventories consisted of the following (in thousands):

	December 28, 2024		March 30, 2024
Raw materials	$	78,631	$	78,241
Work in process	30,027		27,977
Finished goods	134,641		135,121
	$	243,299	$	241,339

XML

Consumer Loans Receivable

9 Months Ended

Dec. 28, 2024

Receivables [Abstract]

Consumer Loans Receivable

Consumer Loans Receivable

The following table summarizes consumer loans receivable (in thousands):

	December 28, 2024		March 30, 2024
Loans held for investment, previously securitized	$	14,476	$	16,968
Loans held for investment	11,898		12,826
Loans held for sale	23,233		15,140
Construction advances	6,042		722
	55,649		45,656
Deferred financing fees and other, net	(1,088)		(523)
Allowance for loan losses	(925)		(1,066)
	53,636		44,067
Less current portion	(33,242)		(20,713)
	$	20,394	$	23,354

The consumer loans held for investment had the following characteristics:

	December 28, 2024		March 30, 2024
Weighted average contractual interest rate	8.1	%	8.1	%
Weighted average effective interest rate	8.1	%	10.4	%
Weighted average months to maturity	210		196

The following table is a consolidated summary of the delinquency status of the outstanding principal balance of consumer loans receivable (in thousands):

	December 28, 2024		March 30, 2024
Current	$	53,709	$	43,810
31 to 60 days	996		1,063
61 to 90 days	373		131
91+ days	571		652
	$	55,649	$	45,656

The following table disaggregates the outstanding principal balance of consumer loans receivable by credit quality indicator and fiscal year of origination (in thousands):

	December 28, 2024
	2025		2024		2023		2022		2021		Prior		Total
Prime- FICO score 680 and greater	$	15,726	$	9,225	$	324	$	93	$	766	$	13,859	$	39,993
Near Prime- FICO score 620-679	2,426		1,325		—		—		1,033		8,874		13,658
Sub-Prime- FICO score less than 620	310		—		—		—		17		695		1,022
No FICO score	252		443		—		—		—		281		976
	$	18,714	$	10,993	$	324	$	93	$	1,816	$	23,709	$	55,649

	March 30, 2024
	2024		2023		2022		2021		2020		Prior		Total
Prime- FICO score 680 and greater	$	14,107	$	328	$	96	$	885	$	1,808	$	14,425	$	31,649
Near Prime- FICO score 620-679	1,633		—		—		1,202		942		8,684		12,461
Sub-Prime- FICO score less than 620	—		—		—		18		49		723		790
No FICO score	447		—		—		—		—		309		756
	$	16,187	$	328	$	96	$	2,105	$	2,799	$	24,141	$	45,656

As of December 28, 2024, 55% of the outstanding principal balance of the consumer loans receivable portfolio was concentrated in Texas. As of March 30, 2024, 46% of the outstanding principal balance of the consumer loans receivable portfolio was concentrated in Texas and 10% was concentrated in Florida. Other than Texas and Florida, no state had concentrations in excess of 10% of the outstanding principal balance of the consumer loans receivable as of December 28, 2024 or March 30, 2024.

Commercial Loans Receivable

The commercial loans receivable balance consists of direct financing arrangements for the home product needs of our independent distributors, community owners and developers.

Commercial loans receivable, net consisted of the following (in thousands):

	December 28, 2024		March 30, 2024
Loans receivable	$	94,902	$	91,938
Allowance for loan losses	(335)		(781)
Deferred financing fees, net	(214)		(116)
	94,353		91,041
Less current portion of commercial loans receivable (including from affiliates), net	(36,250)		(43,316)
	$	58,103	$	47,725

The commercial loans receivable balance had the following characteristics:

	December 28, 2024		March 30, 2024
Weighted average contractual interest rate	7.7	%	7.4	%
Weighted average months outstanding	10		12

Nonperforming status includes loans accounted for on a non-accrual basis and accruing loans with principal payments 90 days or more past due. As of December 28, 2024 and March 30, 2024, there were no commercial loans considered nonperforming. The following table disaggregates the outstanding principal balance of our commercial loans receivable by fiscal year of origination (in thousands):

	December 28, 2024
	2025		2024		2023		2022		2021		Total
Performing	$	54,916	$	27,832	$	8,734	$	1,466	$	1,954	$	94,902

	March 30, 2024
	2024		2023		2022		2021		2020		Total
Performing	$	57,691	$	25,066	$	4,823	$	2,144	$	2,214	$	91,938

As of December 28, 2024 and March 30, 2024, there were no commercial loans 90 days or more past due that were still accruing interest, and we were not aware of any potential problem loans that would have a material effect on the commercial loans receivable balance.

As of December 28, 2024, we had concentrations of our outstanding principal balance of the commercial loans receivable balance in New York of 18% and California of 16%. As of March 30, 2024, 18% of our outstanding principal balance of the commercial loans receivable balance was in New York. No other state had concentrations in excess of 10% of the outstanding principal balance of the commercial loans receivable as of December 28, 2024 or March 30, 2024.

As of December 28, 2024 and March 30, 2024, one independent third-party and its affiliates comprised 10% and 13%, respectively, of the net commercial loans receivable principal balance outstanding, all of which are secured.

XML

Commercial Loans Receivable

9 Months Ended

Dec. 28, 2024

Receivables [Abstract]

Commercial Loans Receivable

Consumer Loans Receivable

The following table summarizes consumer loans receivable (in thousands):

	December 28, 2024		March 30, 2024
Loans held for investment, previously securitized	$	14,476	$	16,968
Loans held for investment	11,898		12,826
Loans held for sale	23,233		15,140
Construction advances	6,042		722
	55,649		45,656
Deferred financing fees and other, net	(1,088)		(523)
Allowance for loan losses	(925)		(1,066)
	53,636		44,067
Less current portion	(33,242)		(20,713)
	$	20,394	$	23,354

The consumer loans held for investment had the following characteristics:

	December 28, 2024		March 30, 2024
Weighted average contractual interest rate	8.1	%	8.1	%
Weighted average effective interest rate	8.1	%	10.4	%
Weighted average months to maturity	210		196

The following table is a consolidated summary of the delinquency status of the outstanding principal balance of consumer loans receivable (in thousands):

	December 28, 2024		March 30, 2024
Current	$	53,709	$	43,810
31 to 60 days	996		1,063
61 to 90 days	373		131
91+ days	571		652
	$	55,649	$	45,656

The following table disaggregates the outstanding principal balance of consumer loans receivable by credit quality indicator and fiscal year of origination (in thousands):

	December 28, 2024
	2025		2024		2023		2022		2021		Prior		Total
Prime- FICO score 680 and greater	$	15,726	$	9,225	$	324	$	93	$	766	$	13,859	$	39,993
Near Prime- FICO score 620-679	2,426		1,325		—		—		1,033		8,874		13,658
Sub-Prime- FICO score less than 620	310		—		—		—		17		695		1,022
No FICO score	252		443		—		—		—		281		976
	$	18,714	$	10,993	$	324	$	93	$	1,816	$	23,709	$	55,649

	March 30, 2024
	2024		2023		2022		2021		2020		Prior		Total
Prime- FICO score 680 and greater	$	14,107	$	328	$	96	$	885	$	1,808	$	14,425	$	31,649
Near Prime- FICO score 620-679	1,633		—		—		1,202		942		8,684		12,461
Sub-Prime- FICO score less than 620	—		—		—		18		49		723		790
No FICO score	447		—		—		—		—		309		756
	$	16,187	$	328	$	96	$	2,105	$	2,799	$	24,141	$	45,656

As of December 28, 2024, 55% of the outstanding principal balance of the consumer loans receivable portfolio was concentrated in Texas. As of March 30, 2024, 46% of the outstanding principal balance of the consumer loans receivable portfolio was concentrated in Texas and 10% was concentrated in Florida. Other than Texas and Florida, no state had concentrations in excess of 10% of the outstanding principal balance of the consumer loans receivable as of December 28, 2024 or March 30, 2024.

Commercial Loans Receivable

The commercial loans receivable balance consists of direct financing arrangements for the home product needs of our independent distributors, community owners and developers.

Commercial loans receivable, net consisted of the following (in thousands):

	December 28, 2024		March 30, 2024
Loans receivable	$	94,902	$	91,938
Allowance for loan losses	(335)		(781)
Deferred financing fees, net	(214)		(116)
	94,353		91,041
Less current portion of commercial loans receivable (including from affiliates), net	(36,250)		(43,316)
	$	58,103	$	47,725

The commercial loans receivable balance had the following characteristics:

	December 28, 2024		March 30, 2024
Weighted average contractual interest rate	7.7	%	7.4	%
Weighted average months outstanding	10		12

Nonperforming status includes loans accounted for on a non-accrual basis and accruing loans with principal payments 90 days or more past due. As of December 28, 2024 and March 30, 2024, there were no commercial loans considered nonperforming. The following table disaggregates the outstanding principal balance of our commercial loans receivable by fiscal year of origination (in thousands):

	December 28, 2024
	2025		2024		2023		2022		2021		Total
Performing	$	54,916	$	27,832	$	8,734	$	1,466	$	1,954	$	94,902

	March 30, 2024
	2024		2023		2022		2021		2020		Total
Performing	$	57,691	$	25,066	$	4,823	$	2,144	$	2,214	$	91,938

As of December 28, 2024 and March 30, 2024, there were no commercial loans 90 days or more past due that were still accruing interest, and we were not aware of any potential problem loans that would have a material effect on the commercial loans receivable balance.

As of December 28, 2024, we had concentrations of our outstanding principal balance of the commercial loans receivable balance in New York of 18% and California of 16%. As of March 30, 2024, 18% of our outstanding principal balance of the commercial loans receivable balance was in New York. No other state had concentrations in excess of 10% of the outstanding principal balance of the commercial loans receivable as of December 28, 2024 or March 30, 2024.

As of December 28, 2024 and March 30, 2024, one independent third-party and its affiliates comprised 10% and 13%, respectively, of the net commercial loans receivable principal balance outstanding, all of which are secured.

XML

Accrued Expenses and Other Current Liabilities

9 Months Ended

Dec. 28, 2024

Payables and Accruals [Abstract]

Accrued Expenses and Other Current Liabilities

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	December 28, 2024		March 30, 2024
Salaries, wages and benefits	$	44,338	$	38,125
Customer deposits	39,795		40,856
Estimated warranties	34,412		31,718
Unearned insurance premiums	33,419		33,449
Accrued volume rebates	30,481		21,167
Insurance loss reserves	12,254		10,540
Accrued insurance	12,226		14,124
Other	52,209		49,757
	$	259,134	$	239,736

XML

Warranties

9 Months Ended

Dec. 28, 2024

Product Warranties Disclosures [Abstract]

Warranties

Warranties

Activity in the liability for estimated warranties was as follows (in thousands):

	Three Months Ended				Nine Months Ended
	December 28, 2024		December 30, 2023		December 28, 2024		December 30, 2023
Balance at beginning of period	$	33,081	$	33,015	$	31,718	$	31,368
Charged to costs and expenses	14,322		11,341		40,403		36,956
Payments and deductions	(12,991)		(11,534)		(37,709)		(35,502)
Balance at end of period	$	34,412	$	32,822	$	34,412	$	32,822

XML

Other Liabilities

9 Months Ended

Dec. 28, 2024

Debt Disclosure [Abstract]

Other Liabilities

Other Liabilities

The following table summarizes secured financings and other obligations (in thousands):

	December 28, 2024		March 30, 2024
Finance lease liabilities	$	6,106	$	6,166
Other secured financing	1,622		1,916
	7,728		8,082
Less current portion included in Accrued expenses and other current liabilities	(522)		(323)
	$	7,206	$	7,759

XML

Debt

9 Months Ended

Dec. 28, 2024

Debt Disclosure [Abstract]

Debt

Debt

On November 12, 2024, the Company entered into that certain Amended and Restated Credit Agreement among the Company, Bank of America, N.A., as administrative agent, swing line lender, letter of credit issuer, and the guarantors party thereto (the "Credit Agreement"), providing for a $75 million revolving credit facility (the "Revolving Credit Facility"), including a $10 million letter of credit sub-facility. The Revolving Credit Facility matures on November 12, 2029. The Credit Agreement amends and restates the previous credit agreement between the parties entered into on November 22, 2022.

Loans under the Revolving Credit Facility will bear interest at a rate equal to (i) the Secured Overnight Financing Rate, plus a credit spread adjustment of 0.10% (as adjusted, "Term SOFR"), plus the "applicable rate" or (ii) the "base rate" (defined as the highest of (a) the Bank of America prime rate, (b) the Federal Funds rate plus 0.50%, and (c) Term SOFR plus 1.00%) plus the "applicable rate." The applicable rate will be determined in accordance with a pricing grid based on the Company's Consolidated Total Leverage Ratio (as defined in the Credit Agreement) ranging from 1.25% to 1.50% per annum for Term SOFR rate loans and from 0.25% to 0.50% per annum for base rate loans. In addition, the Company will pay a commitment fee on the unused portion of the Revolving Credit Facility of 0.20% per annum.

The Revolving Credit Facility is guaranteed, on a joint and several basis, by certain of the Company's subsidiaries. Subject to certain conditions and requirements set forth in the Credit Agreement, including the availability of additional lender commitments, the Company may request from time to time one or more term loan facilities, or increases in the aggregate commitments under the Revolving Credit Facility, in an aggregate amount not exceeding $75 million.

The Credit Agreement contains customary representations and warranties, affirmative and negative covenants (including restrictions, subject to customary exceptions, qualifications, and baskets, on the ability of the Company and its subsidiaries to incur additional indebtedness or guarantees of indebtedness, pay dividends or distributions on, redeem, repurchase, or retire capital stock, make investments, loans, advances, or acquisitions, enter into sale and leaseback transactions, engage in transactions with affiliates, create liens, transfer or sell assets, create restrictions

on the payment of dividends or other distributions from subsidiaries, and consolidate, merge, or transfer all or substantially all of the assets of the Company and its subsidiaries taken as a whole), and events of default (as defined in the Credit Agreement).

In addition, the Credit Agreement includes the following financial covenants (i) as of the end of any fiscal quarter, the Consolidated Total Leverage Ratio (as defined in the Credit Agreement) cannot exceed 3.25 to 1.00 and (ii) a requirement to maintain Consolidated EBITDA (as defined in the Credit Agreement) for any period of four fiscal quarters of at least $75 million.

As of December 28, 2024 and March 30, 2024, there were no borrowings outstanding under the Revolving Credit Facility or the previous credit agreement entered into on November 22, 2022 and we were in compliance with all covenants.

XML

Reinsurance and Insurance Loss Reserves

9 Months Ended

Dec. 28, 2024

Insurance [Abstract]

Reinsurance and Insurance Loss Reserves

Reinsurance and Insurance Loss Reserves

Certain of Standard Casualty Company's premiums and benefits are assumed from and ceded to other insurance companies under various reinsurance agreements. We remain obligated for amounts ceded in the event that the reinsurers do not meet their obligations.

The effects of reinsurance on premiums written and earned were as follows (in thousands):

	Three Months Ended
	December 28, 2024				December 30, 2023
	Written		Earned		Written		Earned
Direct premiums	$	19,260	$	24,645	$	11,135	$	10,693
Assumed premiums—nonaffiliated	21,534		20,629		8,430		8,459
Ceded premiums—nonaffiliated	(17,387)		(17,387)		(6,406)		(6,406)
	$	23,407	$	27,887	$	13,159	$	12,746
	Nine Months Ended
	December 28, 2024				December 30, 2023
	Written		Earned		Written		Earned
Direct premiums	$	32,763	$	36,947	$	31,581	$	28,740
Assumed premiums—nonaffiliated	33,269		30,133		27,735		25,880
Ceded premiums—nonaffiliated	(25,572)		(25,572)		(18,971)		(18,971)
	$	40,460	$	41,508	$	40,345	$	35,649

Typical insurance policies written or assumed have a maximum coverage of $0.4 million per claim, of which we cede $0.15 million of the risk of loss per reinsurance. Therefore, our risk of loss is limited to $0.25 million per claim on typical policies, subject to the reinsurers meeting their obligations. After this limit, amounts are recoverable through reinsurance for catastrophic losses in excess of $4.0 million per occurrence, up to a maximum of $110 million in the aggregate for that occurrence.

The following details the activity in the incurred but not reported reserve for the three and nine months ended December 28, 2024 and December 30, 2023 (in thousands):

	Three Months Ended				Nine Months Ended
	December 28, 2024		December 30, 2023		December 28, 2024		December 30, 2023
Balance at beginning of period	$	14,620	$	9,154	$	10,540	$	10,939
Net incurred losses during the period	9,662		9,489		41,753		29,152
Net claim payments during the period	(12,028)		(9,189)		(40,039)		(30,637)
Balance at end of period	$	12,254	$	9,454	$	12,254	$	9,454

XML

Commitments and Contingencies

9 Months Ended

Dec. 28, 2024

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Repurchase Contingencies. The maximum amount for which the Company was liable under the terms of repurchase agreements with financial institutions that provide inventory financing to independent distributors of our products approximated $122 million and $121 million at December 28, 2024 and March 30, 2024, respectively, without reduction for the estimated resale value of the homes. In the quarter ended December 28, 2024 we received one repurchase demand notice for two homes. In all cases, the estimated fair value exceeded the repurchase price so no loss reserve was deemed necessary. Our reserve for repurchase commitments, recorded in Accrued expenses and other current liabilities, was $3.2 million at December 28, 2024 and $2.9 million at March 30, 2024.

Construction-Period Mortgages. Loan contracts with off-balance sheet commitments are summarized below (in thousands):

	December 28, 2024		March 30, 2024
Construction loan contract amount	$	12,669	$	1,960
Cumulative advances	(6,042)		(722)
	$	6,627	$	1,238

Representations and Warranties of Mortgages Sold. The reserve for contingent repurchases and indemnification obligations was $0.7 million as of December 28, 2024 and $0.6 million as of March 30, 2024, included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets. There were no claim requests that resulted in the repurchase of any loans during the nine months ended December 28, 2024 or December 30, 2023.

Interest Rate Lock Commitments ("IRLCs"). As of December 28, 2024 and March 30, 2024, we had outstanding IRLCs with a notional amount of $10.1 million and $39.0 million, respectively. For the three and nine months ended December 28, 2024, we recognized insignificant non-cash losses and gains, respectively, on outstanding IRLCs. For the three and nine months ended December 30, 2023, we recognized insignificant non-cash gains and losses on outstanding IRLCs.

Forward Sales Commitments. As of December 28, 2024 and March 30, 2024, we had $15.0 million and $2.8 million in outstanding forward sales commitments for sales of mortgage backed securities and whole loan commitments (collectively, the "Commitments"), respectively. During the three and nine months ended December 28, 2024, we recognized insignificant non-cash gains. During the three and nine months ended December 30, 2023, we recognized insignificant non-cash losses.

Legal Matters. We are party to certain lawsuits in the ordinary course of business. Based on management's present knowledge of the facts and (in certain cases) advice of outside counsel, management does not believe that loss contingencies arising from pending matters are likely to have a material adverse effect on our consolidated financial position, liquidity or results of operations after taking into account any existing reserves, which reserves are included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets. However, future events or circumstances that may currently be unknown to management will determine whether the resolution of pending or threatened litigation or claims will ultimately have a material effect on our consolidated financial position, liquidity or results of operations in any future reporting periods.

XML

Stockholders' Equity and Redeemable Noncontrolling Interest

9 Months Ended

Dec. 28, 2024

Stockholders' Equity Note [Abstract]

Stockholders' Equity and Redeemable Noncontrolling Interest

Stockholders' Equity and Redeemable Noncontrolling Interest

The following tables represent changes in stockholders' equity attributable to Cavco's stockholders and redeemable noncontrolling interest during the nine months ended December 28, 2024 and December 30, 2023, respectively (dollars in thousands):

	Equity Attributable to Cavco Stockholders
				Treasury stock		Additional paid-in capital		Retained earnings		Accumulated other comprehensive (loss) income		Total
	Common Stock
	Shares	Amount
Balance, March 30, 2024	9,389,953	$	94	$	(274,693)	$	281,216	$	1,027,127	$	(333)	$	1,033,411
Net income	—	—		—		—		34,429		—		34,429
Other comprehensive income, net	—	—		—		—		—		58		58
Net issuance of common stock under stock incentive plans	11,104	—		—		(2,348)		—		—		(2,348)
Stock-based compensation	—	—		—		2,194		—		—		2,194
Common stock repurchases				(29,204)								(29,204)
Balance, June 29, 2024	9,401,057	94		(303,897)		281,062		1,061,556		(275)		1,038,540
Net income	—	—		—		—		43,815		—		43,815
Other comprehensive income, net	—	—		—		—		—		198		198
Net issuance of common stock under stock incentive plans	16,275			—		1,220		—		—		1,220
Stock-based compensation	—	—		—		2,713		—		—		2,713
Common stock repurchases	—	—		(44,509)		—		—		—		(44,509)
Balance, September 28, 2024	9,417,332	94		(348,406)		284,995		1,105,371		(77)		1,041,977
Net income	—	—		—		—		56,462		—		56,462
Other comprehensive income, net	—	—		—		—		—		(70)		(70)
Net issuance of common stock under stock incentive plans	5,637	—		—		(168)		—		—		(168)
Stock-based compensation	—	—		—		1,746		—		—		1,746
Common stock repurchases	—	—		(42,722)		—		—		—		(42,722)
Balance, December 28, 2024	9,422,969	$	94	$	(391,128)	$	286,573	$	1,161,833	$	(147)	$	1,057,225

	Equity Attributable to Cavco Stockholders
				Treasury stock		Additional paid-in capital		Retained earnings		Accumulated other comprehensive (loss) income		Total		Redeemable noncontrolling interest
	Common Stock
	Shares	Amount
Balance, April 1, 2023	9,337,125	$	93	$	(164,452)	$	271,950	$	869,310	$	(615)	$	976,286	$	1,219
Net income	—	—		—		—		46,357		—		46,357		54
Other comprehensive loss, net	—	—		—		—		—		(42)		(42)		—
Net issuance of common stock under stock incentive plans	10,095	—		—		(1,213)		—		—		(1,213)		—
Stock-based compensation	—	—		—		1,438		—		—		1,438		—
Distributions	—	—		—		—		—		—		—		(120)
Valuation adjustment	—	—		—		—		—		—		—		(33)
Balance, July 1, 2023	9,347,220	93		(164,452)		272,175		915,667		(657)		1,022,826		1,120
Net income	—	—		—		—		41,539		—		41,539		34
Other comprehensive income, net	—	—		—		—		—		54		54		—
Net issuance of common stock under stock incentive plans	9,201	1		—		478		—		—		479		—
Stock-based compensation	—	—		—		1,551		—		—		1,551		—
Common stock repurchases	—	—		(47,194)		—		—		—		(47,194)		—
Distributions	—	—		—		—		—		—		—		(180)
Conversion to mandatorily redeemable noncontrolling interest	—	—		—		—		—		—		—		(974)
Balance, September 30, 2023	9,356,421	94		(211,646)		274,204		957,206		(603)		1,019,255		—
Net income	—	—		—		—		35,987		—		35,987		—
Other comprehensive income, net	—	—		—		—		—		241		241		—
Net issuance of common stock under stock incentive plans	24,726	—		—		1,934		—		—		1,934		—
Stock-based compensation	—	—		—		1,709		—		—		1,709		—
Common stock repurchases	—	—		(50,426)		—		—		—		(50,426)		—
Balance, December 30, 2023	9,381,147	$	94	$	(262,072)	$	277,847	$	993,193	$	(362)	$	1,008,700	$	—

XML

Earnings Per Share

9 Months Ended

Dec. 28, 2024

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share (dollars in thousands, except per share amounts):

	Three Months Ended				Nine Months Ended
	December 28, 2024		December 30, 2023		December 28, 2024		December 30, 2023
Net income attributable to Cavco common stockholders	$	56,462	$	35,987	$	134,706	$	123,883
Weighted average shares outstanding
Basic	8,096,538		8,358,389		8,203,448		8,561,209
Effect of dilutive securities	90,276		74,082		88,199		79,079
Diluted	8,186,814		8,432,471		8,291,647		8,640,288
Net income per share attributable to Cavco common stockholders
Basic	$	6.97	$	4.31	$	16.42	$	14.47
Diluted	$	6.90	$	4.27	$	16.25	$	14.34
Anti-dilutive common stock equivalents excluded	—		—		169		316

XML

Fair Value Measurements

9 Months Ended

Dec. 28, 2024

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair Value Measurements

The book value and estimated fair value of our financial instruments were as follows (in thousands):

	December 28, 2024				March 30, 2024
	Book Value		Estimated Fair Value		Book Value		Estimated Fair Value
Available-for-sale debt securities	$	21,783	$	21,783	$	18,669	$	18,669
Marketable equity securities	7,434		7,434		11,961		11,961
Non-marketable equity investments	5,132		5,132		4,956		4,956
Consumer loans receivable	53,636		57,114		44,067		49,105
Commercial loans receivable	94,353		79,664		91,041		80,764
Other secured financing	(1,622)		(1,536)		(1,916)		(1,841)

See Note 20, Fair Value Measurements, and the Fair Value of Financial Instruments caption in Note 1, Summary of Significant Accounting Policies, in the Form 10-K for more information on the methodologies we use in determining fair value.

Mortgage Servicing. Mortgage Servicing Rights ("MSRs") are recorded at fair value in Prepaid expenses and other current assets on the Consolidated Balance Sheets.

	December 28, 2024			March 30, 2024
Number of loans serviced with MSRs	3,693			3,842
Weighted average servicing fee (basis points)	34.80			34.79
Capitalized servicing multiple	186.29		%	188.59		%
Capitalized servicing rate (basis points)	64.83			65.61
Serviced portfolio with MSRs (in thousands)	$	458,268		$	482,898
MSRs (in thousands)	$	2,971		$	3,168

XML

Business Segment Information

9 Months Ended

Dec. 28, 2024

Segment Reporting [Abstract]

Business Segment Information

Business Segment Information

We operate principally in two segments: (1) factory-built housing, which includes wholesale and retail factory-built housing operations, and (2) financial services, which includes manufactured housing consumer finance and insurance. The following table provides selected financial data by segment (in thousands):

	Three Months Ended				Nine Months Ended
	December 28, 2024		December 30, 2023		December 28, 2024		December 30, 2023
Net revenue:
Factory-built housing	$	500,860	$	426,939	$	1,445,251	$	1,318,114
Financial services	21,180		19,830		61,849		56,560
	$	522,040	$	446,769	$	1,507,100	$	1,374,674
Income (loss) before income taxes:
Factory-built housing	$	63,150	$	42,070	$	168,155	$	154,121
Financial services	6,186		1,837		(8)		2,124
	$	69,336	$	43,907	$	168,147	$	156,245

	December 28, 2024		March 30, 2024
Total assets:
Factory-built housing	$	1,160,795	$	1,141,237
Financial services	224,972		212,923
	$	1,385,767	$	1,354,160

XML

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 56,462	$ 35,987	$ 134,706	$ 123,883

XML

Insider Trading Arrangements

3 Months Ended

9 Months Ended

Dec. 28, 2024

shares

Dec. 28, 2024

shares

Trading Arrangements, by Individual

Non-Rule 10b5-1 Arrangement Adopted

false

Non-Rule 10b5-1 Arrangement Terminated

false

Julia Sze [Member]

Trading Arrangements, by Individual

Material Terms of Trading Arrangement

On December 10, 2024, Julia Sze, a director, terminated her previously adopted plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1(c). This plan was entered into on August 9, 2024, was set to end on December 10, 2024, and provided for the sale of 250 shares of our Common Stock.

Name

Julia Sze

Title

director

Rule 10b5-1 Arrangement Terminated

true

Termination Date

December 10, 2024

Aggregate Available

250

250

David Greenblatt [Member]

Trading Arrangements, by Individual

Material Terms of Trading Arrangement

On December 4, 2024, David Greenblatt, a director, adopted a programmed plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1(c) (the "Greenblatt 10b5-1 Plan"). This plan provides for a first possible trade date of March 5, 2025, and terminates automatically on April 15, 2025, if not before. The aggregate number of shares to potentially be sold pursuant to the Greenblatt 10b5-1 Plan is up to 4,000 shares of Common Stock.

Name

David Greenblatt

Title

director

Rule 10b5-1 Arrangement Adopted

true

Adoption Date

December 4, 2024

Arrangement Duration

41 days

Aggregate Available

4,000

4,000

Seth Schuknecht [Member]

Trading Arrangements, by Individual

Material Terms of Trading Arrangement

On December 5, 2024, Seth Schuknecht, Executive Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary also adopted a programmed plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1(c) (the "Schuknecht 10b5-1 Plan"). This plan provides for a first possible trade date of

March 6, 2025, and terminates automatically on October 31, 2025, if not before. The aggregate number of shares to potentially be sold pursuant to the Schuknecht 10b5-1 Plan is up to 167 shares of Common Stock.

Name

Seth Schuknecht

Title

Executive Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary

Rule 10b5-1 Arrangement Adopted

true

Adoption Date

On December 5, 2024

Arrangement Duration

239 days

Aggregate Available

167

167

XML

Basis of Presentation (Policies)

9 Months Ended

Dec. 28, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Principles of Consolidation

The accompanying unaudited Consolidated Financial Statements of Cavco Industries, Inc. and its subsidiaries (collectively, "we," "us," "our," the "Company" or "Cavco") have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC") for Quarterly Reports on Form 10-Q and Article 10 of SEC Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP") have been condensed or omitted pursuant to such rules and regulations. In addition, references throughout to numbered "Notes" refer to these Notes to Consolidated Financial Statements (Unaudited), unless otherwise stated.

In the opinion of management, these financial statements include all adjustments, including normal recurring adjustments, which are necessary to fairly state the interim results for the periods presented. We have evaluated subsequent events after the balance sheet date through the date of the filing of this report with the SEC, and there were no disclosable subsequent events. These Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and the Notes to the Consolidated Financial Statements included in our 2024 Annual Report on Form 10-K for the year ended March 30, 2024, filed with the SEC ("Form 10-K").

Accounting Estimate

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and accompanying Notes. Due to uncertainties, actual results could differ from the estimates and assumptions used in preparation of the Consolidated Financial Statements.

Fiscal Year

The Consolidated Statements of Comprehensive Income and Consolidated Statements of Cash Flows for the interim periods are not necessarily indicative of the results or cash flows for the full year. The Company operates on a 52-53 week fiscal year ending on the Saturday nearest to March 31st of each year. Each fiscal quarter consists of 13 weeks, with an occasional fourth quarter extending to 14 weeks, if necessary, for the fiscal year to end on the Saturday nearest March 31st. The current fiscal year will end on March 29, 2025 and will include 52 weeks.

Recent Accounting Pronouncements

The Company considers the applicability and impact of all Accounting Standards Updates ("ASUs") issued by the Financial Accounting Standards Board ("FASB"). ASUs not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on the Company's Consolidated Financial Statements.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Taxes Disclosures, which requires greater disaggregation of income tax disclosures. The new standard requires additional information to be disclosed with respect to the income tax rate reconciliation and income taxes paid disaggregated by jurisdiction. This ASU should be applied prospectively for fiscal years beginning after December 15, 2024, with retrospective application permitted. The Company is currently evaluating the impacts of this guidance on the Company’s Consolidated Financial Statements.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires companies to enhance the disclosures about segment expenses. The new standard requires the identification and disclosure of the Company’s Chief Operating Decision Maker ("CODM"), expanded incremental line-item disclosures of significant segment expenses used by the CODM for decision-making, and the inclusion of previous annual only segment disclosure requirements on a quarterly basis. This ASU should be applied retrospectively for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impacts of this guidance on the Company’s Consolidated Financial Statements.

In November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses ("ASU 2024-03"), and in January 2025, the FASB issued ASU No. 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date ("ASU 2025-01"). ASU 2024-03 requires additional disclosure of the nature of expenses included in the income statement as well as disclosures about specific types of expenses included in the expense captions presented in the income statement. ASU 2024-03, as clarified by ASU 2025-01, is effective for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Both early adoption and retrospective application are permitted. The Company is currently evaluating the impact that the adoption of these standards will have on its Consolidated Financial Statements.

Repurchase Contingencies

Repurchase Contingencies. The maximum amount for which the Company was liable under the terms of repurchase agreements with financial institutions that provide inventory financing to independent distributors of our products approximated $122 million and $121 million at December 28, 2024 and March 30, 2024, respectively, without reduction for the estimated resale value of the homes. In the quarter ended December 28, 2024 we received one repurchase demand notice for two homes. In all cases, the estimated fair value exceeded the repurchase price so no loss reserve was deemed necessary. Our reserve for repurchase commitments, recorded in Accrued expenses and other current liabilities, was $3.2 million at December 28, 2024 and $2.9 million at March 30, 2024

Representations and Warranties of Mortgages Sold

Representations and Warranties of Mortgages Sold. The reserve for contingent repurchases and indemnification obligations was $0.7 million as of December 28, 2024 and $0.6 million as of March 30, 2024, included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets. There were no claim requests that resulted in the repurchase of any loans during the nine months ended December 28, 2024 or December 30, 2023.

Interest Rate Lock Commitments and Forward Sales Commitments

Interest Rate Lock Commitments ("IRLCs"). As of December 28, 2024 and March 30, 2024, we had outstanding IRLCs with a notional amount of $10.1 million and $39.0 million, respectively. For the three and nine months ended December 28, 2024, we recognized insignificant non-cash losses and gains, respectively, on outstanding IRLCs. For the three and nine months ended December 30, 2023, we recognized insignificant non-cash gains and losses on outstanding IRLCs.

Forward Sales Commitments. As of December 28, 2024 and March 30, 2024, we had $15.0 million and $2.8 million in outstanding forward sales commitments for sales of mortgage backed securities and whole loan commitments (collectively, the "Commitments"), respectively. During the three and nine months ended December 28, 2024, we recognized insignificant non-cash gains. During the three and nine months ended December 30, 2023, we recognized insignificant non-cash losses.

Mortgage Servicing

Mortgage Servicing. Mortgage Servicing Rights ("MSRs") are recorded at fair value in Prepaid expenses and other current assets on the Consolidated Balance Sheets.

XML

Revenue from Contracts with Customers (Tables)

9 Months Ended

Dec. 28, 2024

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table summarizes Net revenue disaggregated by reportable segment and source (in thousands):

	Three Months Ended				Nine Months Ended
	December 28, 2024		December 30, 2023		December 28, 2024		December 30, 2023
Factory-built housing
Home sales	$	471,998	$	400,633	$	1,378,103	$	1,250,417
Delivery, setup and other revenues	28,862		26,306		67,148		67,697
	500,860		426,939		1,445,251		1,318,114
Financial services
Insurance agency commissions received from third-party insurance companies	1,246		1,229		3,920		3,145
All other sources	19,934		18,601		57,929		53,415
	21,180		19,830		61,849		56,560
	$	522,040	$	446,769	$	1,507,100	$	1,374,674

XML

Investments (Tables)

9 Months Ended

Dec. 28, 2024

Investments, Debt and Equity Securities [Abstract]

Schedule of Investments

Investments consisted of the following (in thousands):

	December 28, 2024		March 30, 2024
Available-for-sale debt securities	$	21,783	$	18,669
Marketable equity securities	7,434		11,961
Non-marketable equity investments	5,132		4,956
	34,349		35,586
Less short-term investments	(16,062)		(18,270)
	$	18,287	$	17,316

Schedule of Available-for-Sale Securities Reconciliation

The amortized cost and fair value of our investments in available-for-sale debt securities, by security type, are shown in the table below (in thousands):

	December 28, 2024				March 30, 2024
	Amortized Cost		Fair Value		Amortized Cost		Fair Value
Residential mortgage-backed securities	$	4,146	$	4,093	$	2,933	$	2,865
State and political subdivision debt securities	6,565		6,515		5,041		4,930
Corporate debt securities	11,257		11,175		11,117		10,874
	$	21,968	$	21,783	$	19,091	$	18,669

Schedule of Contractual Maturity of Investment Securities

The amortized cost and fair value of our investments in available-for-sale debt securities, by contractual maturity, are shown in the table below (in thousands). Expected maturities may differ from contractual maturities as borrowers at times have the right to call or prepay obligations, with or without penalties.

	December 28, 2024
	Amortized Cost		Fair Value
Due in less than one year	$	8,402	$	8,332
Due after one year through five years	7,088		7,047
Due after five years through ten years	2,332		2,311
Mortgage-backed securities	4,146		4,093
	$	21,968	$	21,783

Schedule of Gain (Loss) on Securities

Net investment gains and losses on marketable equity securities were as follows (in thousands):

	Three Months Ended				Nine Months Ended
	December 28, 2024		December 30, 2023		December 28, 2024		December 30, 2023
Marketable equity securities
Net gain (loss) recognized during the period	$	(954)	$	776	$	(440)	$	1,051
Less: Net (gain) recognized on securities sold during the period	(1,649)		(235)		(1,561)		(365)
Unrealized gain (loss) recognized during the period on securities still held	$	(2,603)	$	541	$	(2,001)	$	686

XML

Inventories (Tables)

9 Months Ended

Dec. 28, 2024

Inventory Disclosure [Abstract]

Schedule of Inventory

Inventories consisted of the following (in thousands):

	December 28, 2024		March 30, 2024
Raw materials	$	78,631	$	78,241
Work in process	30,027		27,977
Finished goods	134,641		135,121
	$	243,299	$	241,339

XML

Consumer Loans Receivable (Tables)

9 Months Ended

Dec. 28, 2024

Receivables [Abstract]

Schedule of Accounts, Notes, Loans and Financing Receivable

The following table summarizes consumer loans receivable (in thousands):

	December 28, 2024		March 30, 2024
Loans held for investment, previously securitized	$	14,476	$	16,968
Loans held for investment	11,898		12,826
Loans held for sale	23,233		15,140
Construction advances	6,042		722
	55,649		45,656
Deferred financing fees and other, net	(1,088)		(523)
Allowance for loan losses	(925)		(1,066)
	53,636		44,067
Less current portion	(33,242)		(20,713)
	$	20,394	$	23,354

Commercial loans receivable, net consisted of the following (in thousands):

	December 28, 2024		March 30, 2024
Loans receivable	$	94,902	$	91,938
Allowance for loan losses	(335)		(781)
Deferred financing fees, net	(214)		(116)
	94,353		91,041
Less current portion of commercial loans receivable (including from affiliates), net	(36,250)		(43,316)
	$	58,103	$	47,725

Schedule of Consumer Loans Held for Investment Characteristics

The consumer loans held for investment had the following characteristics:

	December 28, 2024		March 30, 2024
Weighted average contractual interest rate	8.1	%	8.1	%
Weighted average effective interest rate	8.1	%	10.4	%
Weighted average months to maturity	210		196

Schedule of Financing Receivable, Modified

The following table is a consolidated summary of the delinquency status of the outstanding principal balance of consumer loans receivable (in thousands):

	December 28, 2024		March 30, 2024
Current	$	53,709	$	43,810
31 to 60 days	996		1,063
61 to 90 days	373		131
91+ days	571		652
	$	55,649	$	45,656

Schedule of Financing Receivable Credit Quality Indicators

The following table disaggregates the outstanding principal balance of consumer loans receivable by credit quality indicator and fiscal year of origination (in thousands):

	December 28, 2024
	2025		2024		2023		2022		2021		Prior		Total
Prime- FICO score 680 and greater	$	15,726	$	9,225	$	324	$	93	$	766	$	13,859	$	39,993
Near Prime- FICO score 620-679	2,426		1,325		—		—		1,033		8,874		13,658
Sub-Prime- FICO score less than 620	310		—		—		—		17		695		1,022
No FICO score	252		443		—		—		—		281		976
	$	18,714	$	10,993	$	324	$	93	$	1,816	$	23,709	$	55,649

	March 30, 2024
	2024		2023		2022		2021		2020		Prior		Total
Prime- FICO score 680 and greater	$	14,107	$	328	$	96	$	885	$	1,808	$	14,425	$	31,649
Near Prime- FICO score 620-679	1,633		—		—		1,202		942		8,684		12,461
Sub-Prime- FICO score less than 620	—		—		—		18		49		723		790
No FICO score	447		—		—		—		—		309		756
	$	16,187	$	328	$	96	$	2,105	$	2,799	$	24,141	$	45,656

The following table disaggregates the outstanding principal balance of our commercial loans receivable by fiscal year of origination (in thousands):

	December 28, 2024
	2025		2024		2023		2022		2021		Total
Performing	$	54,916	$	27,832	$	8,734	$	1,466	$	1,954	$	94,902

	March 30, 2024
	2024		2023		2022		2021		2020		Total
Performing	$	57,691	$	25,066	$	4,823	$	2,144	$	2,214	$	91,938

XML

Commercial Loans Receivables (Tables)

9 Months Ended

Dec. 28, 2024

Receivables [Abstract]

Schedule of Accounts, Notes, Loans and Financing Receivable

The following table summarizes consumer loans receivable (in thousands):

	December 28, 2024		March 30, 2024
Loans held for investment, previously securitized	$	14,476	$	16,968
Loans held for investment	11,898		12,826
Loans held for sale	23,233		15,140
Construction advances	6,042		722
	55,649		45,656
Deferred financing fees and other, net	(1,088)		(523)
Allowance for loan losses	(925)		(1,066)
	53,636		44,067
Less current portion	(33,242)		(20,713)
	$	20,394	$	23,354

Commercial loans receivable, net consisted of the following (in thousands):

	December 28, 2024		March 30, 2024
Loans receivable	$	94,902	$	91,938
Allowance for loan losses	(335)		(781)
Deferred financing fees, net	(214)		(116)
	94,353		91,041
Less current portion of commercial loans receivable (including from affiliates), net	(36,250)		(43,316)
	$	58,103	$	47,725

Schedule of Commercial Loans Receivable Characteristics

The commercial loans receivable balance had the following characteristics:

	December 28, 2024		March 30, 2024
Weighted average contractual interest rate	7.7	%	7.4	%
Weighted average months outstanding	10		12

Schedule of Commercial Loans Receivables by Class and Internal Credit Quality Indicator

The following table disaggregates the outstanding principal balance of consumer loans receivable by credit quality indicator and fiscal year of origination (in thousands):

	December 28, 2024
	2025		2024		2023		2022		2021		Prior		Total
Prime- FICO score 680 and greater	$	15,726	$	9,225	$	324	$	93	$	766	$	13,859	$	39,993
Near Prime- FICO score 620-679	2,426		1,325		—		—		1,033		8,874		13,658
Sub-Prime- FICO score less than 620	310		—		—		—		17		695		1,022
No FICO score	252		443		—		—		—		281		976
	$	18,714	$	10,993	$	324	$	93	$	1,816	$	23,709	$	55,649

	March 30, 2024
	2024		2023		2022		2021		2020		Prior		Total
Prime- FICO score 680 and greater	$	14,107	$	328	$	96	$	885	$	1,808	$	14,425	$	31,649
Near Prime- FICO score 620-679	1,633		—		—		1,202		942		8,684		12,461
Sub-Prime- FICO score less than 620	—		—		—		18		49		723		790
No FICO score	447		—		—		—		—		309		756
	$	16,187	$	328	$	96	$	2,105	$	2,799	$	24,141	$	45,656

The following table disaggregates the outstanding principal balance of our commercial loans receivable by fiscal year of origination (in thousands):

	December 28, 2024
	2025		2024		2023		2022		2021		Total
Performing	$	54,916	$	27,832	$	8,734	$	1,466	$	1,954	$	94,902

	March 30, 2024
	2024		2023		2022		2021		2020		Total
Performing	$	57,691	$	25,066	$	4,823	$	2,144	$	2,214	$	91,938

XML

Accrued Expenses and Other Current Liabilities (Tables)

9 Months Ended

Dec. 28, 2024

Payables and Accruals [Abstract]

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	December 28, 2024		March 30, 2024
Salaries, wages and benefits	$	44,338	$	38,125
Customer deposits	39,795		40,856
Estimated warranties	34,412		31,718
Unearned insurance premiums	33,419		33,449
Accrued volume rebates	30,481		21,167
Insurance loss reserves	12,254		10,540
Accrued insurance	12,226		14,124
Other	52,209		49,757
	$	259,134	$	239,736

XML

Warranties (Tables)

9 Months Ended

Dec. 28, 2024

Product Warranties Disclosures [Abstract]

Schedule of Activity in the Liability for Estimated Warranties

Activity in the liability for estimated warranties was as follows (in thousands):

	Three Months Ended				Nine Months Ended
	December 28, 2024		December 30, 2023		December 28, 2024		December 30, 2023
Balance at beginning of period	$	33,081	$	33,015	$	31,718	$	31,368
Charged to costs and expenses	14,322		11,341		40,403		36,956
Payments and deductions	(12,991)		(11,534)		(37,709)		(35,502)
Balance at end of period	$	34,412	$	32,822	$	34,412	$	32,822

XML

Other Liabilities (Tables)

9 Months Ended

Dec. 28, 2024

Debt Disclosure [Abstract]

Schedule of Other Liabilities

The following table summarizes secured financings and other obligations (in thousands):

	December 28, 2024		March 30, 2024
Finance lease liabilities	$	6,106	$	6,166
Other secured financing	1,622		1,916
	7,728		8,082
Less current portion included in Accrued expenses and other current liabilities	(522)		(323)
	$	7,206	$	7,759

XML

Reinsurance and Insurance Loss Reserves (Tables)

9 Months Ended

Dec. 28, 2024

Insurance [Abstract]

Schedule of Effects of Reinsurance

The effects of reinsurance on premiums written and earned were as follows (in thousands):

	Three Months Ended
	December 28, 2024				December 30, 2023
	Written		Earned		Written		Earned
Direct premiums	$	19,260	$	24,645	$	11,135	$	10,693
Assumed premiums—nonaffiliated	21,534		20,629		8,430		8,459
Ceded premiums—nonaffiliated	(17,387)		(17,387)		(6,406)		(6,406)
	$	23,407	$	27,887	$	13,159	$	12,746
	Nine Months Ended
	December 28, 2024				December 30, 2023
	Written		Earned		Written		Earned
Direct premiums	$	32,763	$	36,947	$	31,581	$	28,740
Assumed premiums—nonaffiliated	33,269		30,133		27,735		25,880
Ceded premiums—nonaffiliated	(25,572)		(25,572)		(18,971)		(18,971)
	$	40,460	$	41,508	$	40,345	$	35,649

Schedule of Loss Reserve Rollforward

The following details the activity in the incurred but not reported reserve for the three and nine months ended December 28, 2024 and December 30, 2023 (in thousands):

	Three Months Ended				Nine Months Ended
	December 28, 2024		December 30, 2023		December 28, 2024		December 30, 2023
Balance at beginning of period	$	14,620	$	9,154	$	10,540	$	10,939
Net incurred losses during the period	9,662		9,489		41,753		29,152
Net claim payments during the period	(12,028)		(9,189)		(40,039)		(30,637)
Balance at end of period	$	12,254	$	9,454	$	12,254	$	9,454

XML

Commitments and Contingencies (Tables)

9 Months Ended

Dec. 28, 2024

Commitments and Contingencies Disclosure [Abstract]

Schedule of Loan Contracts with Off-Balance Sheet Commitments

Construction-Period Mortgages. Loan contracts with off-balance sheet commitments are summarized below (in thousands):

	December 28, 2024		March 30, 2024
Construction loan contract amount	$	12,669	$	1,960
Cumulative advances	(6,042)		(722)
	$	6,627	$	1,238

XML

Stockholders' Equity and Redeemable Noncontrolling Interest (Tables)

9 Months Ended

Dec. 28, 2024

Stockholders' Equity Note [Abstract]

Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest

The following tables represent changes in stockholders' equity attributable to Cavco's stockholders and redeemable noncontrolling interest during the nine months ended December 28, 2024 and December 30, 2023, respectively (dollars in thousands):

	Equity Attributable to Cavco Stockholders
				Treasury stock		Additional paid-in capital		Retained earnings		Accumulated other comprehensive (loss) income		Total
	Common Stock
	Shares	Amount
Balance, March 30, 2024	9,389,953	$	94	$	(274,693)	$	281,216	$	1,027,127	$	(333)	$	1,033,411
Net income	—	—		—		—		34,429		—		34,429
Other comprehensive income, net	—	—		—		—		—		58		58
Net issuance of common stock under stock incentive plans	11,104	—		—		(2,348)		—		—		(2,348)
Stock-based compensation	—	—		—		2,194		—		—		2,194
Common stock repurchases				(29,204)								(29,204)
Balance, June 29, 2024	9,401,057	94		(303,897)		281,062		1,061,556		(275)		1,038,540
Net income	—	—		—		—		43,815		—		43,815
Other comprehensive income, net	—	—		—		—		—		198		198
Net issuance of common stock under stock incentive plans	16,275			—		1,220		—		—		1,220
Stock-based compensation	—	—		—		2,713		—		—		2,713
Common stock repurchases	—	—		(44,509)		—		—		—		(44,509)
Balance, September 28, 2024	9,417,332	94		(348,406)		284,995		1,105,371		(77)		1,041,977
Net income	—	—		—		—		56,462		—		56,462
Other comprehensive income, net	—	—		—		—		—		(70)		(70)
Net issuance of common stock under stock incentive plans	5,637	—		—		(168)		—		—		(168)
Stock-based compensation	—	—		—		1,746		—		—		1,746
Common stock repurchases	—	—		(42,722)		—		—		—		(42,722)
Balance, December 28, 2024	9,422,969	$	94	$	(391,128)	$	286,573	$	1,161,833	$	(147)	$	1,057,225

	Equity Attributable to Cavco Stockholders
				Treasury stock		Additional paid-in capital		Retained earnings		Accumulated other comprehensive (loss) income		Total		Redeemable noncontrolling interest
	Common Stock
	Shares	Amount
Balance, April 1, 2023	9,337,125	$	93	$	(164,452)	$	271,950	$	869,310	$	(615)	$	976,286	$	1,219
Net income	—	—		—		—		46,357		—		46,357		54
Other comprehensive loss, net	—	—		—		—		—		(42)		(42)		—
Net issuance of common stock under stock incentive plans	10,095	—		—		(1,213)		—		—		(1,213)		—
Stock-based compensation	—	—		—		1,438		—		—		1,438		—
Distributions	—	—		—		—		—		—		—		(120)
Valuation adjustment	—	—		—		—		—		—		—		(33)
Balance, July 1, 2023	9,347,220	93		(164,452)		272,175		915,667		(657)		1,022,826		1,120
Net income	—	—		—		—		41,539		—		41,539		34
Other comprehensive income, net	—	—		—		—		—		54		54		—
Net issuance of common stock under stock incentive plans	9,201	1		—		478		—		—		479		—
Stock-based compensation	—	—		—		1,551		—		—		1,551		—
Common stock repurchases	—	—		(47,194)		—		—		—		(47,194)		—
Distributions	—	—		—		—		—		—		—		(180)
Conversion to mandatorily redeemable noncontrolling interest	—	—		—		—		—		—		—		(974)
Balance, September 30, 2023	9,356,421	94		(211,646)		274,204		957,206		(603)		1,019,255		—
Net income	—	—		—		—		35,987		—		35,987		—
Other comprehensive income, net	—	—		—		—		—		241		241		—
Net issuance of common stock under stock incentive plans	24,726	—		—		1,934		—		—		1,934		—
Stock-based compensation	—	—		—		1,709		—		—		1,709		—
Common stock repurchases	—	—		(50,426)		—		—		—		(50,426)		—
Balance, December 30, 2023	9,381,147	$	94	$	(262,072)	$	277,847	$	993,193	$	(362)	$	1,008,700	$	—

XML

Earnings Per Share (Tables)

9 Months Ended

Dec. 28, 2024

Earnings Per Share [Abstract]

Schedule of Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share (dollars in thousands, except per share amounts):

	Three Months Ended				Nine Months Ended
	December 28, 2024		December 30, 2023		December 28, 2024		December 30, 2023
Net income attributable to Cavco common stockholders	$	56,462	$	35,987	$	134,706	$	123,883
Weighted average shares outstanding
Basic	8,096,538		8,358,389		8,203,448		8,561,209
Effect of dilutive securities	90,276		74,082		88,199		79,079
Diluted	8,186,814		8,432,471		8,291,647		8,640,288
Net income per share attributable to Cavco common stockholders
Basic	$	6.97	$	4.31	$	16.42	$	14.47
Diluted	$	6.90	$	4.27	$	16.25	$	14.34
Anti-dilutive common stock equivalents excluded	—		—		169		316

XML

Fair Value Measurements (Tables)

9 Months Ended

Dec. 28, 2024

Fair Value Disclosures [Abstract]

Schedule of the Fair Value and Carrying Value of Financial Instruments

The book value and estimated fair value of our financial instruments were as follows (in thousands):

	December 28, 2024				March 30, 2024
	Book Value		Estimated Fair Value		Book Value		Estimated Fair Value
Available-for-sale debt securities	$	21,783	$	21,783	$	18,669	$	18,669
Marketable equity securities	7,434		7,434		11,961		11,961
Non-marketable equity investments	5,132		5,132		4,956		4,956
Consumer loans receivable	53,636		57,114		44,067		49,105
Commercial loans receivable	94,353		79,664		91,041		80,764
Other secured financing	(1,622)		(1,536)		(1,916)		(1,841)

Schedule of Assumptions for Mortgage Servicing Rights

	December 28, 2024			March 30, 2024
Number of loans serviced with MSRs	3,693			3,842
Weighted average servicing fee (basis points)	34.80			34.79
Capitalized servicing multiple	186.29		%	188.59		%
Capitalized servicing rate (basis points)	64.83			65.61
Serviced portfolio with MSRs (in thousands)	$	458,268		$	482,898
MSRs (in thousands)	$	2,971		$	3,168

XML

Business Segment Information (Tables)

9 Months Ended

Dec. 28, 2024

Segment Reporting [Abstract]

Schedule of Business Segment Information

The following table provides selected financial data by segment (in thousands):

	Three Months Ended				Nine Months Ended
	December 28, 2024		December 30, 2023		December 28, 2024		December 30, 2023
Net revenue:
Factory-built housing	$	500,860	$	426,939	$	1,445,251	$	1,318,114
Financial services	21,180		19,830		61,849		56,560
	$	522,040	$	446,769	$	1,507,100	$	1,374,674
Income (loss) before income taxes:
Factory-built housing	$	63,150	$	42,070	$	168,155	$	154,121
Financial services	6,186		1,837		(8)		2,124
	$	69,336	$	43,907	$	168,147	$	156,245

	December 28, 2024		March 30, 2024
Total assets:
Factory-built housing	$	1,160,795	$	1,141,237
Financial services	224,972		212,923
	$	1,385,767	$	1,354,160

XML

Revenue from Contracts with Customers - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Disaggregation of Revenue [Line Items]
Net revenue	$ 522,040	$ 446,769	$ 1,507,100	$ 1,374,674
Factory-built housing
Disaggregation of Revenue [Line Items]
Net revenue	500,860	426,939	1,445,251	1,318,114
Factory-built housing | Home sales
Disaggregation of Revenue [Line Items]
Net revenue	471,998	400,633	1,378,103	1,250,417
Factory-built housing | Delivery, setup and other revenues
Disaggregation of Revenue [Line Items]
Net revenue	28,862	26,306	67,148	67,697
Financial services
Disaggregation of Revenue [Line Items]
Net revenue	21,180	19,830	61,849	56,560
Financial services | Insurance agency commissions received from third-party insurance companies
Disaggregation of Revenue [Line Items]
Net revenue	1,246	1,229	3,920	3,145
Financial services | All other sources
Disaggregation of Revenue [Line Items]
Net revenue	$ 19,934	$ 18,601	$ 57,929	$ 53,415

XML

Investments - Schedule of Investments (Details) - USD ($) $ in Thousands	Dec. 28, 2024	Mar. 30, 2024
Investments, Debt and Equity Securities [Abstract]
Available-for-sale debt securities	$ 21,783	$ 18,669
Marketable equity securities	7,434	11,961
Non-marketable equity investments	5,132	4,956
Investments	34,349	35,586
Less short-term investments	(16,062)	(18,270)
Investments	$ 18,287	$ 17,316

XML

Investments - Schedule of Amortized Cost and Fair Value (Details) - USD ($) $ in Thousands	Dec. 28, 2024	Mar. 30, 2024
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 21,968	$ 19,091
Fair Value	21,783	18,669
Residential mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	4,146	2,933
Fair Value	4,093	2,865
State and political subdivision debt securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	6,565	5,041
Fair Value	6,515	4,930
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	11,257	11,117
Fair Value	$ 11,175	$ 10,874

XML

Investments - Schedule of Contractual Maturities (Details) - USD ($) $ in Thousands	Dec. 28, 2024	Mar. 30, 2024
Amortized Cost
Due in less than one year	$ 8,402
Due after one year through five years	7,088
Due after five years through ten years	2,332
Mortgage-backed securities	4,146
Amortized Cost	21,968	$ 19,091
Fair Value
Due in less than one year	8,332
Due after one year through five years	7,047
Due after five years through ten years	2,311
Mortgage-backed securities	4,093
Fair Value	$ 21,783	$ 18,669

XML

Investments - Schedule of Recognized Gains and Losses (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Net gain (loss) recognized during the period	$ (954)	$ 776	$ (440)	$ 1,051
Less: Net (gain) recognized on securities sold during the period	(1,649)	(235)	(1,561)	(365)
Unrealized gain (loss) recognized during the period on securities still held	$ (2,603)	$ 541	$ (2,001)	$ 686

XML

Inventories (Details) - USD ($) $ in Thousands	Dec. 28, 2024	Mar. 30, 2024
Summary of inventories
Raw materials	$ 78,631	$ 78,241
Work in process	30,027	27,977
Finished goods	134,641	135,121
Total inventories	$ 243,299	$ 241,339

XML

Consumer Loans Receivable - Schedule of Consumer Loans Receivable (Details) - USD ($) $ in Thousands	Dec. 28, 2024	Mar. 30, 2024
Accounts, Notes, Loans and Financing Receivable [Line Items]
Construction advances	$ 6,042	$ 722
Consumer Loans Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans held for investment, previously securitized	14,476	16,968
Loans held for investment	11,898	12,826
Loans held for sale	23,233	15,140
Construction advances	6,042	722
Loans receivable, gross	55,649	45,656
Deferred financing fees and other, net	(1,088)	(523)
Allowance for loan losses	(925)	(1,066)
Loans receivable, net	53,636	44,067
Less current portion	(33,242)	(20,713)
Loans receivable, net	$ 20,394	$ 23,354

XML

Consumer Loans Receivable - Schedule of Weighted Averages (Details) - Consumer Loans Receivable	9 Months Ended	12 Months Ended
	Dec. 28, 2024	Mar. 30, 2024
Accounts, Notes, Loans and Financing Receivable [Line Items]
Weighted average contractual interest rate	8.10%	8.10%
Weighted average effective interest rate	8.10%	10.40%
Weighted average months to maturity	210 months	196 months

XML

Consumer Loans Receivable - Schedule of Delinquency Status of Consumer Loans (Details) - Consumer Loans Receivable - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Dec. 28, 2024	Mar. 30, 2024
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable	$ 55,649	$ 45,656
Current
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable	53,709	43,810
31 to 60 days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable	996	1,063
61 to 90 days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable	373	131
91+ days
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable	$ 571	$ 652

XML

Consumer Loans Receivable - Schedule of Consumer Loan Receivables by Segment and Credit Quality Indicator (Details) - Consumer Loans Receivable - USD ($) $ in Thousands	Dec. 28, 2024	Mar. 30, 2024
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans by origination year, one	$ 18,714	$ 16,187
Loans by origination year, two	10,993	328
Loans by origination year, three	324	96
Loans by origination year, four	93	2,105
Loans by origination year, five	1,816	2,799
Prior	23,709	24,141
Loans receivable, gross	55,649	45,656
Prime- FICO score 680 and greater
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans by origination year, one	15,726	14,107
Loans by origination year, two	9,225	328
Loans by origination year, three	324	96
Loans by origination year, four	93	885
Loans by origination year, five	766	1,808
Prior	13,859	14,425
Loans receivable, gross	39,993	31,649
Near Prime- FICO score 620-679
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans by origination year, one	2,426	1,633
Loans by origination year, two	1,325	0
Loans by origination year, three	0	0
Loans by origination year, four	0	1,202
Loans by origination year, five	1,033	942
Prior	8,874	8,684
Loans receivable, gross	13,658	12,461
Sub-Prime- FICO score less than 620
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans by origination year, one	310	0
Loans by origination year, two	0	0
Loans by origination year, three	0	0
Loans by origination year, four	0	18
Loans by origination year, five	17	49
Prior	695	723
Loans receivable, gross	1,022	790
No FICO score
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans by origination year, one	252	447
Loans by origination year, two	443	0
Loans by origination year, three	0	0
Loans by origination year, four	0	0
Loans by origination year, five	0	0
Prior	281	309
Loans receivable, gross	$ 976	$ 756

XML

Consumer Loans Receivable - Narrative (Details) - Financing Receivable - Geographic Concentration Risk - Consumer Loans Receivable	9 Months Ended	12 Months Ended
	Dec. 28, 2024	Mar. 30, 2024
TEXAS
Accounts, Notes, Loans and Financing Receivable [Line Items]
Concentration risk, percentage	55.00%	46.00%
FLORIDA
Accounts, Notes, Loans and Financing Receivable [Line Items]
Concentration risk, percentage		10.00%

XML

Commercial Loans Receivable - Schedule of Commercial Loans Notes Receivables, Net (Details) - Commercial Loans Receivable - USD ($) $ in Thousands	Dec. 28, 2024	Mar. 30, 2024
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans receivable	$ 94,902	$ 91,938
Allowance for loan losses	(335)	(781)
Deferred financing fees, net	(214)	(116)
Loans receivable, net	94,353	91,041
Less current portion of commercial loans receivable (including from affiliates), net	(36,250)	(43,316)
Loans receivable, net	$ 58,103	$ 47,725

XML

Commercial Loans Receivable - Schedule of Commercial Loans Characteristics (Details) - Commercial Loans Receivable	9 Months Ended	12 Months Ended
	Dec. 28, 2024	Mar. 30, 2024
Accounts, Notes, Loans and Financing Receivable [Line Items]
Weighted average contractual interest rate	7.70%	7.40%
Weighted average months outstanding	10 months	12 months

XML

Commercial Loans Receivable - Narrative (Details) - Commercial Loans Receivable - USD ($)	9 Months Ended	12 Months Ended
	Dec. 28, 2024	Mar. 30, 2024
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, nonperforming, threshold	90 days
Commercial loans 90 days past due still accruing interest	$ 0	$ 0
Financing receivable, nonaccrual, threshold period past due	90 days	90 days
Financing Receivable | Customer Concentration Risk
Accounts, Notes, Loans and Financing Receivable [Line Items]
Concentration risk, percentage	10.00%	13.00%
NEW YORK | Financing Receivable | Geographic Concentration Risk
Accounts, Notes, Loans and Financing Receivable [Line Items]
Concentration risk, percentage	18.00%	18.00%
CALIFORNIA | Financing Receivable | Geographic Concentration Risk
Accounts, Notes, Loans and Financing Receivable [Line Items]
Concentration risk, percentage	16.00%

XML

Commercial Loans Receivable - Schedule of Commercial Loans Receivables by Credit Quality Indicator and Year of Origination (Details) - Commercial Loans Receivable - USD ($) $ in Thousands	Dec. 28, 2024	Mar. 30, 2024
Financing Receivable Recorded Investment [Line Items]
Loans receivable, gross	$ 94,902	$ 91,938
Performing
Financing Receivable Recorded Investment [Line Items]
Loans by origination year, one	54,916	57,691
Loans by origination year, two	27,832	25,066
Loans by origination year, three	8,734	4,823
Loans by origination year, four	1,466	2,144
Loans by origination year, five	1,954	2,214
Loans receivable, gross	$ 94,902	$ 91,938

XML

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Dec. 28, 2024	Sep. 28, 2024	Mar. 30, 2024	Dec. 30, 2023	Sep. 30, 2023	Apr. 01, 2023
Accrued Expenses and Other Current Liabilities
Salaries, wages and benefits	$ 44,338		$ 38,125
Customer deposits	39,795		40,856
Estimated warranties	34,412		31,718
Unearned insurance premiums	33,419		33,449
Accrued volume rebates	30,481		21,167
Insurance loss reserves	12,254	$ 14,620	10,540	$ 9,454	$ 9,154	$ 10,939
Accrued insurance	12,226		14,124
Other	52,209		49,757
Total accrued expenses and other current liabilities	$ 259,134		$ 239,736

XML

Warranties (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Accrual for estimated warranties
Balance at beginning of period	$ 33,081	$ 33,015	$ 31,718	$ 31,368
Charged to costs and expenses	14,322	11,341	40,403	36,956
Payments and deductions	(12,991)	(11,534)	(37,709)	(35,502)
Balance at end of period	$ 34,412	$ 32,822	$ 34,412	$ 32,822

XML

Other Liabilities (Details) - USD ($) $ in Thousands	Dec. 28, 2024	Mar. 30, 2024
Debt Obligations
Finance lease liabilities	$ 6,106	$ 6,166
Other secured financing	1,622	1,916
Other liabilities	7,728	8,082
Less current portion included in Accrued expenses and other current liabilities	(522)	(323)
Other noncurrent liabilities	$ 7,206	$ 7,759

XML

Debt (Details) - Revolving Credit Facility - Line of Credit	Nov. 12, 2024 USD ($)	Dec. 28, 2024 USD ($)	Mar. 30, 2024 USD ($)
The Revolving Credit Facility
Line of Credit Facility [Line Items]
Current borrowing capacity	$ 75,000,000
Line of credit facility, unused capacity, commitment fee percentage	0.20%
Maximum borrowing capacity	$ 75,000,000
Debt instrument, covenant, leverage ratio	3.25
Debt instrument, covenant, EBITDA threshold, minimum	$ 75,000,000
Long-term debt		$ 0	$ 0
The Revolving Credit Facility | Secured Overnight Financing Rate (SOFR)
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate	0.10%
The Revolving Credit Facility | Federal Funds Rate
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate	0.50%
The Revolving Credit Facility | Term Secured Overnight Financing Rate (SOFR)
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate	1.00%
The Revolving Credit Facility | Term Secured Overnight Financing Rate (SOFR) | Minimum [Member]
Line of Credit Facility [Line Items]
Debt instrument, covenant, leverage ratio, percentage	0.0125
The Revolving Credit Facility | Term Secured Overnight Financing Rate (SOFR) | Maximum [Member]
Line of Credit Facility [Line Items]
Debt instrument, covenant, leverage ratio, percentage	0.0150
The Revolving Credit Facility | Base Rate | Minimum [Member]
Line of Credit Facility [Line Items]
Debt instrument, covenant, leverage ratio, percentage	0.0025
The Revolving Credit Facility | Base Rate | Maximum [Member]
Line of Credit Facility [Line Items]
Debt instrument, covenant, leverage ratio, percentage	0.0050
Revolving Credit Facility, Sub-Facility
Line of Credit Facility [Line Items]
Current borrowing capacity	$ 10,000,000

XML

Reinsurance and Insurance Loss Reserves - Schedule of Reinsurance Effect on Premiums Written and Earned (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Written
Direct premiums	$ 19,260	$ 11,135	$ 32,763	$ 31,581
Assumed premiums—nonaffiliated	21,534	8,430	33,269	27,735
Ceded premiums—nonaffiliated	(17,387)	(6,406)	(25,572)	(18,971)
Net premiums written	23,407	13,159	40,460	40,345
Earned
Direct premiums	24,645	10,693	36,947	28,740
Assumed premiums—nonaffiliated	20,629	8,459	30,133	25,880
Ceded premiums—nonaffiliated	(17,387)	(6,406)	(25,572)	(18,971)
Net premiums earned	$ 27,887	$ 12,746	$ 41,508	$ 35,649

XML

Reinsurance and Insurance Loss Reserves - Narrative (Details) $ in Thousands	9 Months Ended
	Dec. 28, 2024 USD ($)
Insurance [Abstract]
Insurance policies maximum coverage per claim	$ 400
Insurance policies coverage per claim ceded to reinsurers	150
Insurance policy risk of loss maintained per claim	250
Catastrophic losses recoverable in excess of amount	4,000
Aggregate catastrophic losses recoverable in excess of amount	$ 110,000

XML

Reinsurance and Insurance Loss Reserves - Schedule of Loss Reserve Rollforward (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense [Roll Forward]
Balance at beginning of period	$ 14,620	$ 9,154	$ 10,540	$ 10,939
Net incurred losses during the period	9,662	9,489	41,753	29,152
Net claim payments during the period	(12,028)	(9,189)	(40,039)	(30,637)
Balance at end of period	$ 12,254	$ 9,454	$ 12,254	$ 9,454

XML

Commitments and Contingencies - Narrative (Details) $ in Millions	3 Months Ended
	Dec. 28, 2024 USD ($) home demandNotice	Mar. 30, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Repurchase agreements maximum amount contingently liable	$ 122.0	$ 121.0
Number of repurchase demand notice | demandNotice	1
Number of homes | home	2
Reserve for repurchase commitments	$ 3.2	2.9
Reserves related to consumer loans sold	0.7	0.6
IRLCs recorded at fair value	10.1	39.0
Forward commitments recorded at fair value	$ 15.0	$ 2.8

XML

Commitments and Contingencies - Schedule of Loan Contracts with Off-Balance Sheet Commitments (Details) - USD ($) $ in Thousands	Dec. 28, 2024	Mar. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Construction loan contract amount	$ 12,669	$ 1,960
Cumulative advances	(6,042)	(722)
Remaining construction contingent commitment	$ 6,627	$ 1,238

XML

Stockholders' Equity and Redeemable Noncontrolling Interest (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 28, 2024	Sep. 28, 2024	Jun. 29, 2024	Dec. 30, 2023	Sep. 30, 2023	Jul. 01, 2023
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance, common stock (in shares)			8,320,718
Beginning balance	$ 1,041,977	$ 1,038,540	$ 1,033,411	$ 1,019,255	$ 1,022,826	$ 976,286
Net income	56,462	43,815	34,429	35,987	41,539	46,357
Other comprehensive income (loss), net	(70)	198	58	241	54	(42)
Net issuance of common stock under stock incentive plans	(168)	1,220	(2,348)	1,934	479	(1,213)
Stock-based compensation	1,746	2,713	2,194	1,709	1,551	1,438
Common stock repurchases	$ (42,722)	(44,509)	(29,204)	(50,426)	(47,194)
Ending balance, common stock (in shares)	8,066,549
Ending balance	$ 1,057,225	$ 1,041,977	$ 1,038,540	1,008,700	1,019,255	1,022,826
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]
Beginning balance				0	1,120	1,219
Net income					34	54
Distributions					(180)	(120)
Valuation adjustment						(33)
Conversion to mandatorily redeemable noncontrolling interest					(974)
Ending balance				$ 0	$ 0	$ 1,120
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance, common stock (in shares)	9,417,332	9,401,057	9,389,953	9,356,421	9,347,220	9,337,125
Beginning balance	$ 94	$ 94	$ 94	$ 94	$ 93	$ 93
Net issuance of common stock under stock incentive plans (in shares)	5,637	16,275	11,104	24,726	9,201	10,095
Net issuance of common stock under stock incentive plans					$ 1
Ending balance, common stock (in shares)	9,422,969	9,417,332	9,401,057	9,381,147	9,356,421	9,347,220
Ending balance	$ 94	$ 94	$ 94	$ 94	$ 94	$ 93
Treasury stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(348,406)	(303,897)	(274,693)	(211,646)	(164,452)	(164,452)
Common stock repurchases	(42,722)	(44,509)	(29,204)	(50,426)	(47,194)
Ending balance	(391,128)	(348,406)	(303,897)	(262,072)	(211,646)	(164,452)
Additional paid-in capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	284,995	281,062	281,216	274,204	272,175	271,950
Net issuance of common stock under stock incentive plans	(168)	1,220	(2,348)	1,934	478	(1,213)
Stock-based compensation	1,746	2,713	2,194	1,709	1,551	1,438
Ending balance	286,573	284,995	281,062	277,847	274,204	272,175
Retained earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	1,105,371	1,061,556	1,027,127	957,206	915,667	869,310
Net income	56,462	43,815	34,429	35,987	41,539	46,357
Ending balance	1,161,833	1,105,371	1,061,556	993,193	957,206	915,667
Accumulated other comprehensive (loss) income
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(77)	(275)	(333)	(603)	(657)	(615)
Other comprehensive income (loss), net	(70)	198	58	241	54	(42)
Ending balance	$ (147)	$ (77)	$ (275)	$ (362)	$ (603)	$ (657)

XML

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net income attributable to Cavco common stockholders	$ 56,462	$ 35,987	$ 134,706	$ 123,883
Weighted average shares outstanding
Basic (in shares)	8,096,538	8,358,389	8,203,448	8,561,209
Effect of dilutive securities (in shares)	90,276	74,082	88,199	79,079
Diluted (in shares)	8,186,814	8,432,471	8,291,647	8,640,288
Net income per share attributable to Cavco common stockholders
Basic (in usd per share)	$ 6.97	$ 4.31	$ 16.42	$ 14.47
Diluted (in usd per share)	$ 6.90	$ 4.27	$ 16.25	$ 14.34
Stock Options
Net income per share attributable to Cavco common stockholders
Anti-dilutive common stock equivalents excluded (in shares)	0	0	169	316

XML

Fair Value Measurements - Schedule of the Fair Value and Carrying Value of Financial Instruments (Details) - USD ($) $ in Thousands	Dec. 28, 2024	Mar. 30, 2024
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Line Items]
Available-for-sale debt securities	$ 21,783	$ 18,669
Marketable equity securities	7,434	11,961
Book Value
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Line Items]
Available-for-sale debt securities	21,783	18,669
Marketable equity securities	7,434	11,961
Non-marketable equity investments	5,132	4,956
Consumer loans receivable	53,636	44,067
Commercial loans receivable	94,353	91,041
Other secured financing	(1,622)	(1,916)
Estimated Fair Value
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Line Items]
Available-for-sale debt securities	21,783	18,669
Marketable equity securities	7,434	11,961
Non-marketable equity investments	5,132	4,956
Consumer loans receivable	57,114	49,105
Commercial loans receivable	79,664	80,764
Other secured financing	$ (1,536)	$ (1,841)

XML

Fair Value Measurements - Schedule of Assumptions for Mortgage Servicing Rights (Details) $ in Thousands	Dec. 28, 2024 USD ($) loan	Mar. 30, 2024 USD ($) loan
Fair Value Disclosures [Abstract]
Number of loans serviced with MSRs | loan	3,693	3,842
Weighted average servicing fee (basis points)	0.348%	0.3479%
Capitalized servicing multiple	186.29%	188.59%
Capitalized servicing rate (basis points)	0.6483%	0.6561%
Serviced portfolio with MSRs (in thousands)	$ 458,268	$ 482,898
MSRs (in thousands)	$ 2,971	$ 3,168

XML

Business Segment Information (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024 USD ($)	Dec. 30, 2023 USD ($)	Dec. 28, 2024 USD ($) segment	Dec. 30, 2023 USD ($)	Mar. 30, 2024 USD ($)
Business Segment Information
Number of operating segments | segment			2
Net revenue	$ 522,040	$ 446,769	$ 1,507,100	$ 1,374,674
Income before income taxes	69,336	43,907	168,147	156,245
Total assets	1,385,767		1,385,767		$ 1,354,160
Factory-built housing
Business Segment Information
Net revenue	500,860	426,939	1,445,251	1,318,114
Income before income taxes	63,150	42,070	168,155	154,121
Total assets	1,160,795		1,160,795		1,141,237
Financial services
Business Segment Information
Net revenue	21,180	19,830	61,849	56,560
Income before income taxes	6,186	$ 1,837	(8)	$ 2,124
Total assets	$ 224,972		$ 224,972		$ 212,923